https://curecurrent.com/trials/assessing-the-benefits-of-a-painless-lancing-device-among-diabetes-patients-16001https://curecurrent.com/trials/a-study-evaluating-the-bioavailability-of-oral-insulin-n11005-16002https://curecurrent.com/trials/vibration-enhances-diabetic-ulcer-healing-16003https://curecurrent.com/trials/mobile-health-application-of-screening-and-early-intervention-for-prediabetic-patient-at-primary-health-cares-setting-16004https://curecurrent.com/trials/a-research-study-looking-at-how-semaglutide-works-in-people-with-type-2-diabetes-in-switzerland-as-part-of-local-clinica-16005https://curecurrent.com/trials/lifestyle-intervention-in-pregnant-women-with-pcos-16006https://curecurrent.com/trials/midfoot-fusion-bolt-mfb-in-the-early-stage-of-diabetic-neuropathic-charcot-feet-16007https://curecurrent.com/trials/data-driven-behavior-intervention-and-medical-outcome-evaluation-of-patients-comprehensive-monitoring-16008https://curecurrent.com/trials/sleep-and-chronotype-in-children-with-type-1-diabetes-16009https://curecurrent.com/trials/microarchitecture-bone-strength-and-fracture-risk-in-long-term-type-1-diabetes-16010https://curecurrent.com/trials/the-predictive-value-of-sidestream-dark-field-imaging-in-diabetic-nephropathy-16011https://curecurrent.com/trials/implications-of-stress-management-program-16012https://curecurrent.com/trials/echocardiographic-assessment-of-the-impact-of-diabetes-and-prognostic-analysis-of-heart-transplantation-16013https://curecurrent.com/trials/effects-of-fixed-meals-with-special-formulated-rice-on-blood-glucose-levels-of-healthy-volunteers-16014https://curecurrent.com/trials/pressure-and-diabetic-foot-16015https://curecurrent.com/trials/establishment-and-clinical-validation-of-a-new-technique-for-early-diagnosis-of-diabetic-nephropathy-16016https://curecurrent.com/trials/effectiveness-of-music-intervention-on-anxiety-and-physiological-responses-in-critical-ill-patient-16017https://curecurrent.com/trials/intervention-study-genetic-risk-communication-and-wearables-16018https://curecurrent.com/trials/multiple-dose-tolerability-and-pharmacokinetic-of-ibi362-in-chinese-patients-with-t2dm-16019https://curecurrent.com/trials/culturally-adapted-diet-for-puerto-rican-adults-16020https://curecurrent.com/trials/mealtime-walking-study-to-improve-postprandial-metabolic-response-16021https://curecurrent.com/trials/rapid-identification-of-minoca-based-on-novel-biomarkers-16022https://curecurrent.com/trials/translating-biometric-data-into-blood-glucose-levels-16023https://curecurrent.com/trials/insulin-therapy-de-intensification-with-iglarlixi-16024https://curecurrent.com/trials/the-assessment-of-the-effect-of-vitamin-d-supplementation-on-inflammatory-and-endothelial-factors-in-the-patients-with-t-16025https://curecurrent.com/trials/effects-of-pramlintide-on-endogenous-production-of-very-low-density-lipoprotein-vldl-triglyceride-and-glucose-in-the-pos-16026https://curecurrent.com/trials/evaluation-of-pharmacokinetics-and-safety-of-aju-a51-in-healthy-adults-16027https://curecurrent.com/trials/a-study-using-swedish-registries-to-find-out-how-many-people-with-type-2-diabetes-had-cardiovascular-disease-and-started-16028https://curecurrent.com/trials/glypalcare-study-multicenter-randomized-study-for-evaluating-continuous-glucose-monitoring-cgm-by-using-freestyle-libre-16029https://curecurrent.com/trials/artificial-intelligence-guided-personalised-medicine-in-patients-with-hypertension-and-diabetes-16030https://curecurrent.com/trials/to-bathe-or-not-to-bathe-16031https://curecurrent.com/trials/at278-and-novorapid-in-glucose-clamp-study-16032https://curecurrent.com/trials/the-drug-drug-interaction-study-of-aju-a51r1-and-aju-a51r2-16033https://curecurrent.com/trials/a-single-blind-stepped-wedge-cluster-randomized-controlled-behaviour-change-trial-to-determine-effectiveness-of-preventi-16034https://curecurrent.com/trials/intermittent-fasting-on-the-incidence-of-gestational-diabetes-mellitus-obese-pregnant-women-in-3rd-trimester-16035https://curecurrent.com/trials/diabetes-type-1-and-fitness-16036https://curecurrent.com/trials/a-study-of-ly3305677-in-participants-with-type-2-diabetes-16037https://curecurrent.com/trials/phase-iib-safety-and-efficacy-study-of-bay94-8862-in-subjects-with-worsening-chronic-heart-failure-and-left-ventricular-16038https://curecurrent.com/trials/a-study-of-the-continuous-glucose-monitoring-system-for-home-use-in-patients-with-diabetes-16039https://curecurrent.com/trials/safety-and-efficacy-of-different-oral-doses-of-bay94-8862-in-japanese-subjects-with-type-2-diabetes-mellitus-and-the-cli-16040https://curecurrent.com/trials/safety-and-efficacy-of-insulin-degludec-insulin-aspart-in-patients-with-t1dm-16041https://curecurrent.com/trials/a-study-to-learn-how-finerenone-bay94-8862-moves-into-through-and-out-of-the-body-how-it-affects-the-body-and-how-safe-i-16042https://curecurrent.com/trials/genetics-of-diabetes-audit-and-research-in-tayside-scotland-dolorisk-dundee-16043https://curecurrent.com/trials/safety-and-efficacy-study-of-medcu-wound-dressings-16044https://curecurrent.com/trials/painful-diabetic-polyneuropathy-trial-with-a-new-centrally-acting-analgesic-16045https://curecurrent.com/trials/safety-and-efficacy-of-grt6005-in-pain-due-to-diabetic-polyneuropathy-16046https://curecurrent.com/trials/multiprofessional-approach-in-diabetes-mellitus-16047https://curecurrent.com/trials/mini-dose-glucagon-to-treat-fasting-induced-hypoglycemia-during-ramadan-16048https://curecurrent.com/trials/ultrasound-assisted-wound-debridement-uaw-versus-standard-wound-treatment-in-complicated-diabetic-foot-ulcers-dfu-16049https://curecurrent.com/trials/a-research-study-looking-at-how-victoza-works-in-people-with-type-2-diabetes-in-iran-followed-in-local-clinical-routine-16050https://curecurrent.com/trials/effect-of-empagliflozin-on-urinary-excretion-of-adenosine-and-osteocyte-function-in-patients-with-chronic-kidney-disease-16051https://curecurrent.com/trials/mean-healing-time-of-wound-after-vacuum-assisted-closure-vac-versus-conventional-dressing-in-diabetic-foot-ulcer-patient-16052https://curecurrent.com/trials/carbohydrates-under-target-for-type-1-diabetes-management-16053https://curecurrent.com/trials/a-study-of-msdc-0602k-to-assess-glycemic-control-and-cardiovascular-outcomes-in-patients-with-pre-t2d-or-t2d-and-nafld-n-16054https://curecurrent.com/trials/newborn-screening-for-genetic-susceptibility-to-type-1-diabetes-and-celiac-disease-and-prospective-follow-up-study-16055https://curecurrent.com/trials/multifactorial-intervention-on-diabetes-midiab-study-16056https://curecurrent.com/trials/life-without-diabetes-16057https://curecurrent.com/trials/self-efficacy-levels-attachment-style-and-resiliency-of-youth-with-type-1-diabetes-16058https://curecurrent.com/trials/dulaglutide-and-insulin-microsecretion-in-type-1-diabetes-16059https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-in-type-2-diabetes-with-lower-extremity-arterial-disease-16060https://curecurrent.com/trials/pilates-method-on-functional-capacity-and-blood-pressure-of-elderly-women-with-type-2-diabetes-16061https://curecurrent.com/trials/pilot-study-on-metabolic-effects-of-fish-peptides-and-vitamin-d-16062https://curecurrent.com/trials/effect-of-roux-en-y-gastric-bypass-or-gastric-sleeve-surgery-on-type-2-diabetes-16063https://curecurrent.com/trials/sglt2-inhibitor-versus-sulfonylurea-on-type-2-diabetes-with-nafld-16064https://curecurrent.com/trials/brazilian-diabetes-study-a-type-2-diabetes-prospective-cohort-16065https://curecurrent.com/trials/a-reduced-carbohydrate-diet-high-in-monounsaturated-fats-in-type-2-diabetes-16066https://curecurrent.com/trials/study-to-learn-more-about-outcomes-reported-by-patients-suffering-from-type-2-diabetes-using-a-digital-data-collection-t-16067https://curecurrent.com/trials/cellular-adaptations-to-training-in-patients-with-type-2-diabetes-16068https://curecurrent.com/trials/efficacy-of-teriparatide-in-diabetic-inactive-charcot-neuroarthropathy-of-foot-16069https://curecurrent.com/trials/comparison-of-premixed-insulins-aspart-30-aspart-70-and-aspart-on-postprandial-lipids-16070https://curecurrent.com/trials/sglt2-inhibition-in-combination-with-diuretics-in-heart-failure-16071https://curecurrent.com/trials/diabetes-mellitus-and-hiv-study-in-mwanza-16072https://curecurrent.com/trials/the-headwind-study-part-2-16073https://curecurrent.com/trials/enteropathy-and-diabetes-in-hiv-patients-16074https://curecurrent.com/trials/efficacy-and-safety-of-metformin-glycinate-compared-to-metformin-hydrochloride-on-the-progression-of-type-2-diabetes-16075https://curecurrent.com/trials/impact-of-long-term-serum-magnesium-and-potassium-levels-optimization-and-multifactorial-adherence-intervention-on-the-p-16076https://curecurrent.com/trials/a-study-of-dbpr108-and-metformin-hydrochloride-combination-therapy-in-patients-with-t2dm-16077https://curecurrent.com/trials/impact-of-the-use-of-a-closed-loop-insulin-therapy-on-the-burden-of-the-diabetes-and-the-quality-of-life-16078https://curecurrent.com/trials/integrated-ncd-intervention-in-rural-nepal-16079https://curecurrent.com/trials/visfatin-and-omentin-1-markers-of-nutritional-status-of-newborns-born-to-diabetic-mothers-16080https://curecurrent.com/trials/alleviating-carbohydrate-counting-burden-in-t1dm-using-artificial-pancreas-and-empagliflozin-16081https://curecurrent.com/trials/impact-of-the-covid-19-epidemic-on-glycemic-balance-and-the-level-of-stress-in-diabetic-patients-16082https://curecurrent.com/trials/effect-of-the-caipadi-care-model-in-relatives-of-patients-with-type-2-diabetes-mellitus-16083https://curecurrent.com/trials/serum-gper-1-and-oxidant-antioxidant-levels-on-retinopathy-in-diabetic-patients-16084https://curecurrent.com/trials/epidemiologic-assessment-of-diabetic-retinopathy-in-egypt-using-ultrawide-field-fundus-photographs-16085https://curecurrent.com/trials/pinit-study-primary-intranasal-insulin-trial-16086https://curecurrent.com/trials/isometric-handgrip-exercise-mri-in-children-and-adolescents-16087https://curecurrent.com/trials/levels-of-neuregulin-4-and-its-receptor-erbb4-in-periodontitis-patients-with-and-without-diabetes-type-2-16088https://curecurrent.com/trials/patient-driven-lifestyle-modification-using-freestyle-libre-in-type-2-diabetes-patients-16089https://curecurrent.com/trials/camostat-and-artemisia-annua-vs-placebo-in-covid-19-outpatients-16090https://curecurrent.com/trials/diet-glucose-gut-microbiome-net-in-women-with-gdm-16091https://curecurrent.com/trials/pathophysiology-of-martorell-hypertensive-ischemic-leg-ulcer-hytilu-16092https://curecurrent.com/trials/low-carbohydrate-diet-in-diabetic-kidney-disease-16093https://curecurrent.com/trials/type-2-diabetes-cardiovascular-comorbidity-and-environmental-temperature-16094https://curecurrent.com/trials/evaluating-safety-of-andiabet-on-diabetes-mellitus-type-ii-patients-phase-i-ct-16095https://curecurrent.com/trials/study-of-the-reliability-of-a-device-humansens-plus-allowing-immediate-measurement-uric-acid-in-the-blood-obtained-by-fi-16096https://curecurrent.com/trials/study-of-the-effect-of-telemedicine-on-glycemic-control-for-patients-with-diabetes-and-treated-with-insulin-16097https://curecurrent.com/trials/comparison-of-two-management-systems-in-patients-with-type-1-diabetes-pediatric-smarthome-16098https://curecurrent.com/trials/fasting-and-postprandial-cerebral-blood-flow-in-type-2-diabetic-patients-16099https://curecurrent.com/trials/pediatric-population-screening-for-type-1-diabetes-and-familial-hypercholesterolemia-in-lower-saxony-germany-16100https://curecurrent.com/trials/efficacy-of-multigrain-supplementation-in-type-ii-diabetes-mellitus-16101https://curecurrent.com/trials/effect-of-glp-1-on-angiogenesis-16102https://curecurrent.com/trials/changes-of-muramyl-dipeptide-in-intestinal-and-extra-intestinal-diseases-16103https://curecurrent.com/trials/clinical-efectivity-of-two-different-sensor-augmented-pumps-with-low-predictive-suspension-function-16104https://curecurrent.com/trials/clinical-data-collection-for-the-closed-loop-development-for-the-type-2-diabetes-treatment-dt2-1-16105https://curecurrent.com/trials/decrease-dapagliflozin-plus-exenatide-on-central-regulation-of-appetite-in-diabetes-type-2-16106https://curecurrent.com/trials/the-effect-of-sleep-hyg-ene-tra-n-ng-on-blood-sugar-regulat-on-16107https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-pharmacokinetic-profiles-and-safety-of-ckd-383-16108https://curecurrent.com/trials/the-effect-effect-of-empagliflozin-on-oxidative-stress-in-patients-with-type-2-diabetes-16109https://curecurrent.com/trials/a-randomized-placebo-controlled-clinical-trial-of-teneligliptin-as-quadruple-oral-combination-therapy-for-type-2-dm-afte-16110https://curecurrent.com/trials/impact-of-exercise-intervention-on-the-phenome-16111https://curecurrent.com/trials/the-headwind-study-16112https://curecurrent.com/trials/cholecalciferol-on-depressive-symptoms-in-type-2-diabetes-mellitus-patients-16113https://curecurrent.com/trials/the-genetics-of-adipose-tissue-function-and-its-link-to-type-2-diabetes-and-heart-disease-16114https://curecurrent.com/trials/insulin-plus-pramlintide-closed-loop-strategy-to-regulate-glucose-levels-without-carbohydrate-counting-16115https://curecurrent.com/trials/a-comparison-between-the-effects-of-conventional-diets-vs-intermittent-fasting-diabetic-and-pre-diabetic-patients-16116https://curecurrent.com/trials/safety-and-efficacy-of-antidiabetic-drugs-in-recently-diagnosed-patients-with-type-2-diabetes-16117https://curecurrent.com/trials/effect-of-fasting-time-before-cesarean-section-on-neonatal-blood-glucose-in-pregnant-women-with-gestational-diabetes-mel-16118https://curecurrent.com/trials/pilot-study-among-type-2-diabetes-patients-investigating-the-effects-of-computerized-cognitive-and-physical-activity-pro-16119https://curecurrent.com/trials/effects-of-a-probiotic-on-oral-microbiota-and-glycemic-control-in-type-2-diabetics-a-randomized-clinical-trial-16120https://curecurrent.com/trials/a-research-study-looking-at-how-tresiba-works-in-people-with-type-2-diabetes-in-local-clinical-practice-in-saudi-arabia-16121https://curecurrent.com/trials/risk-factors-of-metabolic-control-in-children-and-adolescents-with-type-1-diabetes-16122https://curecurrent.com/trials/a-extension-study-of-empagliflozin-in-patients-with-refractory-diabetes-mellitus-with-insulin-resistance-empire-02-16123https://curecurrent.com/trials/coronary-diet-intervention-with-olive-oil-and-cardiovascular-prevention-16124https://curecurrent.com/trials/patiromer-in-the-treatment-of-hyperkalemia-in-patients-with-hypertension-and-diabetic-nephropathy-amethyst-dn-16125https://curecurrent.com/trials/timing-of-initiation-of-continuous-glucose-monitoring-in-established-pediatric-diabetes-the-cgm-time-trial-16126https://curecurrent.com/trials/the-role-of-aldosterone-in-circulatory-disorders-within-type-2-diabetes-16127https://curecurrent.com/trials/efficacy-and-safety-of-dipeptidyl-peptidase-4-inhibitors-in-diabetic-patients-with-established-covid-19-16128https://curecurrent.com/trials/insulin-stimulated-vasodilation-in-patients-with-type-2-diabetes-16129https://curecurrent.com/trials/home-cooking-health-empowerment-strategy-in-people-with-type-ii-diabetes-mellitus-16130https://curecurrent.com/trials/comparative-effects-of-metformin-and-insulin-on-stereological-studies-and-immunohistochemistry-of-placenta-16131https://curecurrent.com/trials/decision-coaching-for-youth-and-parents-considering-insulin-delivery-methods-for-type-1-diabetes-16132https://curecurrent.com/trials/randomized-study-comparing-metabolic-surgery-with-intensive-medical-therapy-to-treat-diabetic-kidney-disease-16133https://curecurrent.com/trials/the-study-will-evaluate-average-24-hr-sodium-excretion-during-dapagliflozin-treatment-in-patients-with-type-2-diabetes-m-16134https://curecurrent.com/trials/clinical-study-on-metabolic-surgery-compared-to-the-best-clinical-treatment-in-patients-with-type-2-diabetes-mellitus-16135https://curecurrent.com/trials/trazodone-gabapentin-fixed-dose-combination-products-in-painful-diabetic-neuropathy-16136https://curecurrent.com/trials/continuous-glucose-monitoring-in-total-knee-arthroplasty-with-preoperative-high-dose-dexamethasone-16137https://curecurrent.com/trials/liver-enriched-antimicrobial-peptide-2-16138https://curecurrent.com/trials/blood-pressure-antihypertensive-treatment-and-preeclampsia-in-pregnant-wom-en-with-pre-existing-diabetes-16139https://curecurrent.com/trials/mesenchymal-stem-cells-in-patients-with-type-1-diabetes-mellitus-16140https://curecurrent.com/trials/effect-of-preoperative-oral-carbohydrates-on-the-glycemic-variability-of-diabetic-patients-16141https://curecurrent.com/trials/a-study-of-ly2963016-compared-to-lantus-in-adult-chinese-participants-with-type-2-diabetes-mellitus-16142https://curecurrent.com/trials/effects-of-linagliptin-on-left-ventricular-myocardial-dysfunction-in-patients-with-type-2-diabetes-mellitus-and-concentr-16143https://curecurrent.com/trials/study-of-efficacy-and-safety-of-the-plasmapheresis-method-with-albumin-compensation-compared-with-the-plasmapheresis-met-16144https://curecurrent.com/trials/regulatory-request-nis-in-korea-16145https://curecurrent.com/trials/a-trial-to-learn-more-about-how-bay2327949-works-and-how-safe-it-is-in-patients-whose-kidneys-are-damaged-due-to-high-bl-16146https://curecurrent.com/trials/efficacy-of-moxibustion-in-diabetes-peripheral-neuropathy-16147https://curecurrent.com/trials/understanding-risk-factors-and-determinants-for-neuropathic-pain-16148https://curecurrent.com/trials/diabetes-mellitus-and-microrna-as-risk-factors-for-mild-cognitive-impairment-impact-of-life-style-modification-16149https://curecurrent.com/trials/study-of-pd-pk-pg-relationships-of-tacrolimus-and-cyclosporin-in-liver-transplant-patients-16150https://curecurrent.com/trials/magnetic-resonance-imaging-and-thermal-imaging-of-adiposity-in-neonates-of-women-with-metabolic-diseases-16151https://curecurrent.com/trials/training-in-shared-decision-making-of-cystic-fibrosis-centers-competences-in-the-treatment-of-cf-related-diabetes-in-adu-16152https://curecurrent.com/trials/exercise-intervention-on-cardiorespiratory-function-in-hf-with-dm-16153https://curecurrent.com/trials/meta-analysis-of-low-gi-gl-diets-and-cardiometabolic-risk-in-diabetes-16154https://curecurrent.com/trials/effects-of-web-based-training-on-hba1c-quality-of-life-and-depression-levels-in-adolescents-with-type-1-diabetes-16155https://curecurrent.com/trials/effects-of-oral-fenofibrate-on-retinal-thickness-and-macular-volume-16156https://curecurrent.com/trials/the-diabetes-patient-reported-outcome-measures-trial-16157https://curecurrent.com/trials/a-trial-for-the-use-of-a-pulsed-electromagnetic-field-device-to-assist-management-of-type-2-diabetes-16158https://curecurrent.com/trials/consequences-of-hypoglycaemia-on-cardiovascular-and-inflammatory-responses-16159https://curecurrent.com/trials/assessing-diabetes-mellitus-on-cytokine-analysis-and-macular-edema-following-flacs-16160https://curecurrent.com/trials/lifestyle-intervention-for-women-with-recent-pre-eclampsia-or-gestational-diabetes-mellitus-mom-s-healthy-heart-16161https://curecurrent.com/trials/effectiveness-of-a-mhealth-intervention-for-the-treatment-of-depression-in-people-with-diabetes-or-hypertension-in-peru-16162https://curecurrent.com/trials/feasibility-of-an-intervention-to-increase-diabetic-retinopathy-screening-attendance-16163https://curecurrent.com/trials/jardiance-regulartory-post-marketing-surveillance-in-korean-type-2-diabetes-mellitus-16164https://curecurrent.com/trials/cpap-effect-on-albuminuria-in-patients-with-diabetic-nephropathy-and-obstructive-sleep-apnea-16165https://curecurrent.com/trials/cpap-effect-on-the-progression-of-diabetic-retinopathy-in-patients-with-sleep-apnea-16166https://curecurrent.com/trials/validation-of-a-predictive-risk-equation-for-type-2-diabetes-in-families-with-risk-16167https://curecurrent.com/trials/diabeloop-for-highly-unstable-type-1-diabetes-16168https://curecurrent.com/trials/stevia-extract-and-glucose-homeostasis-16169https://curecurrent.com/trials/effect-of-metformin-in-children-with-type-1-diabetes-16170https://curecurrent.com/trials/safety-and-performance-assessment-of-drug-eluting-stent-cre8-in-diabetic-patients-16171https://curecurrent.com/trials/vitamin-d-and-type-2-diabetes-risk-in-uk-adults-16172https://curecurrent.com/trials/glucose-dependent-insulinotropic-polypeptide-as-a-safeguard-against-hypoglycemia-in-patients-with-type-1-diabetes-16173https://curecurrent.com/trials/sflt-1-plgf-ratio-in-gestational-diabetes-prediction-preeclampsia-in-diabetic-gestation-study-16174https://curecurrent.com/trials/the-efficacy-and-safety-of-rex-001-to-treat-ischemic-rest-pain-in-subjects-with-cli-rutherford-category-4-and-dm-16175https://curecurrent.com/trials/immunogenicity-after-revaccination-with-23-valent-pneumococcal-polysaccharide-vaccine-healthy-elderly-people-versus-diab-16176https://curecurrent.com/trials/the-management-of-glucose-control-and-hypoglycemic-prevention-using-continuous-glucose-monitoring-system-in-patients-wit-16177https://curecurrent.com/trials/smoking-intervention-among-patients-with-diabetes-16178https://curecurrent.com/trials/aerobic-exercise-in-women-with-gestational-diabetes-16179https://curecurrent.com/trials/delineation-of-the-diabetogenic-role-of-extrapancreatic-glucagon-in-totally-pancreatectomised-patients-using-glucagon-re-16180https://curecurrent.com/trials/effect-of-neprilysin-on-glucagon-like-peptide-1-in-patients-with-type-2-diabetes-16181https://curecurrent.com/trials/effect-of-glucose-on-qtc-interval-in-type-1-diabetes-16182https://curecurrent.com/trials/efficacy-and-safety-study-of-biib074-in-participants-with-small-fiber-neuropathy-16183https://curecurrent.com/trials/motivational-interviewing-with-focus-on-diet-and-weight-gain-in-pregnant-women-with-type-2-diabetes-16184https://curecurrent.com/trials/quadruple-oral-combination-therapy-for-type-2-diabetes-mellitus-glycemic-control-by-thiazolidinedione-tzd-or-sodium-gluc-16185https://curecurrent.com/trials/the-effect-of-covid-19-on-diabetes-mellitus-16186https://curecurrent.com/trials/the-effect-of-diabetes-mellitus-on-the-prognosis-of-patients-with-covid-19-16187https://curecurrent.com/trials/tools-and-practices-to-decrease-cvd-and-complications-in-the-diabetic-population-of-mexico-16188https://curecurrent.com/trials/cardiac-rest-and-stress-metabolism-in-patients-with-type-2-diabetes-16189https://curecurrent.com/trials/integrating-depression-and-diabetes-treatment-independent-study-16190https://curecurrent.com/trials/molecular-analysis-of-diabetic-kidney-disease-biopsies-16191https://curecurrent.com/trials/sub-study-of-the-preview-study-australia-16192https://curecurrent.com/trials/reward-mechanisms-in-obesity-16193https://curecurrent.com/trials/semi-individualised-chinese-medicine-treatment-as-an-adjuvant-management-for-diabetic-nephropathy-16194https://curecurrent.com/trials/clinical-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-ckd-393-in-healthy-subjects-16195https://curecurrent.com/trials/asian-diabetes-outcomes-prevention-trial-16196https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-study-of-glufast-tablets-10mg-mitiglinide-16197https://curecurrent.com/trials/impact-of-rapeseed-and-sunflower-oils-on-proteomic-biomarkers-of-diseases-16198https://curecurrent.com/trials/surviving-pneumonia-16199https://curecurrent.com/trials/metabolic-responses-of-dapagliflozin-vs-sitagliptin-in-t2dm-patients-inadequately-controlled-with-insulin-therapy-16200https://curecurrent.com/trials/korean-observational-study-to-evaluate-the-efficacy-and-safety-of-anagliptin-switching-from-other-dpp4is-in-type2-dm-16201https://curecurrent.com/trials/use-of-dexcom-g6-in-commercial-pilots-with-insulin-treated-diabetes-16202https://curecurrent.com/trials/strategies-to-oppose-sugars-with-non-nutritive-sweeteners-or-water-stop-sugars-now-trial-16203https://curecurrent.com/trials/efficacy-and-safety-of-evoglitin-in-patients-with-type-2-diabetes-and-non-alcoholic-fatty-liver-diseases-16204https://curecurrent.com/trials/examining-the-impact-of-a-self-compassion-intervention-on-physical-activity-behaviour-among-people-with-prediabetes-16205https://curecurrent.com/trials/ketone-supplementation-glucose-control-and-cardiovascular-function-16206https://curecurrent.com/trials/comparison-between-the-effect-of-ultrasound-debridement-and-conventional-treatment-in-diabetic-foot-ulcers-dfu-16207https://curecurrent.com/trials/vitamin-d-in-pregnancy-16208https://curecurrent.com/trials/change-of-lifestyle-in-elderly-patients-with-type-2-diabetes-and-systemic-arterial-hypertension-16209https://curecurrent.com/trials/acute-effect-of-rebaudioside-a-on-glucose-excursion-during-an-oral-glucose-tolerance-test-in-type-2-diabetes-mellitus-16210https://curecurrent.com/trials/early-versus-late-administration-of-insulin-glargine-in-t1dm-during-fasting-ramadan-16211https://curecurrent.com/trials/a-cfit-study-baseline-16212https://curecurrent.com/trials/hypertension-and-diabetes-assessment-in-the-rohingya-refugee-population-and-in-the-host-communities-in-bangladesh-16213https://curecurrent.com/trials/effectiveness-of-ohp-in-improving-self-efficacy-in-patients-with-diabetes-mellitus-16214https://curecurrent.com/trials/obesity-treatment-using-an-internet-delivered-intervention-based-on-the-diabetes-prevention-program-in-mexican-adults-16215https://curecurrent.com/trials/a-cfit-study-acute-exercise-16216https://curecurrent.com/trials/mobile-health-to-enhance-exercise-in-type-2-diabetes-16217https://curecurrent.com/trials/effect-of-gip-after-a-meal-in-patients-with-type-2-diabetes-16218https://curecurrent.com/trials/the-effect-of-a-sglt2-inhibitor-on-glucose-flux-lipolysis-and-exercise-in-type-2-diabetes-16219https://curecurrent.com/trials/covid-19-antobodies-in-pregnant-women-and-their-connection-to-beta-cell-function-in-the-fetus-16220https://curecurrent.com/trials/sirolimus-vs-mycophenolate-with-tacrolimus-in-simultaneous-pancreas-and-kidney-transplantation-16221https://curecurrent.com/trials/is-teaching-people-to-be-self-compassionate-feasible-and-acceptable-for-people-who-are-pre-diabetic-16222https://curecurrent.com/trials/mri-imaging-of-labeled-human-islets-transplanted-into-the-liver-16223https://curecurrent.com/trials/effects-of-antenatal-exercises-on-clinical-outcomes-in-pregnant-females-with-gestational-diabetes-mellitus-16224https://curecurrent.com/trials/the-use-of-early-pregnancy-hba1c-in-predicting-excessive-fetal-growth-in-women-at-risk-of-glucose-intolerance-16225https://curecurrent.com/trials/antimicrobial-photodynamic-therapy-in-chronic-periodontitis-and-diabetes-mellitus-16226https://curecurrent.com/trials/prevention-of-hypoglycemia-among-diabetes-patients-admitted-to-internal-medicine-departments-with-nutritional-care-16227https://curecurrent.com/trials/genetics-of-diabetes-audit-and-research-in-tayside-and-scotland-16228https://curecurrent.com/trials/effect-of-sarpogrelate-on-the-nephropathy-in-type-2-diabetes-sonata-study-16229https://curecurrent.com/trials/ketone-esters-in-t2dm-16230https://curecurrent.com/trials/rtms-on-diabetic-peripheral-neuropathic-pain-16231https://curecurrent.com/trials/pharmacist-led-study-in-controlling-hypoglycemia-in-older-adults-with-type-2-diabetes-mellitus-16232https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cells-therapy-for-diabetic-nephropathy-16233https://curecurrent.com/trials/the-acute-effect-of-physical-activity-on-postprandial-blood-glucose-in-pregnant-women-16234https://curecurrent.com/trials/protective-effects-of-saxagliptin-and-vitamin-d3-on-cell-function-in-adult-onset-latent-autoimmune-diabetes-16235https://curecurrent.com/trials/gut-hormones-and-roux-en-y-gastric-bypass-16236https://curecurrent.com/trials/effects-of-flavanoids-in-essential-hypertension-type-2-diabetes-and-healthy-persons-16237https://curecurrent.com/trials/effects-of-empagliflozin-on-left-ventricular-diastolic-function-compared-to-usual-care-in-type-2-diabetics-16238https://curecurrent.com/trials/omega-3-and-vitamin-d-supplements-in-childhood-t1d-16239https://curecurrent.com/trials/novel-classification-of-adult-onset-diabetes-and-its-association-with-common-microvascular-complications-in-upper-egypt-16240https://curecurrent.com/trials/hearing-screening-outcomes-of-two-screening-tests-in-newborns-of-gestational-diabetic-mothers-16241https://curecurrent.com/trials/acupuncture-in-diabetic-peripheral-neuropathy-16242https://curecurrent.com/trials/tuberculosis-drug-levels-in-diabetics-16243https://curecurrent.com/trials/sokary-mobile-application-with-type-ii-diabetes-16244https://curecurrent.com/trials/multiple-electrode-aggregometry-clopidogrel-resistance-16245https://curecurrent.com/trials/a-study-evaluating-drug-drug-interaction-ddi-between-hsk16149-capsules-and-metformin-hydrochloride-tablets-16246https://curecurrent.com/trials/cardiovascular-risk-and-functional-responses-from-dancing-at-home-in-the-elderly-with-and-without-type-2-diabetes-16247https://curecurrent.com/trials/a-double-blinded-trial-comparing-the-efficacy-and-safety-of-insulin-degludec-liraglutide-and-insulin-degludec-both-in-co-16248https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-safety-of-insulin-degludec-liraglutide-insulin-degludec-and-liraglutide-in-japanese-s-16249https://curecurrent.com/trials/safety-assessment-of-dblus-system-in-adolescent-and-adult-patients-with-type-1-diabetes-and-assessment-of-its-clinical-e-16250https://curecurrent.com/trials/feasibility-and-safety-study-of-the-automated-insulin-delivery-closed-loop-system-pancreas4all-16251https://curecurrent.com/trials/evaluation-of-diabetic-foot-wound-healing-using-hydrogel-nano-silver-based-dressing-vs-traditional-dressing-16252https://curecurrent.com/trials/validation-of-algorithms-for-basal-insulin-rate-reductions-in-type-1-diabetic-patients-practising-physical-activity-in-r-16253https://curecurrent.com/trials/clinical-trial-for-assessment-of-anti-sars-cov-2-serum-for-early-treatment-of-covid-19-cases-16254https://curecurrent.com/trials/metformin-glycinate-in-patients-with-ms-or-dm2-hospitalized-with-covid-19-and-sars-secondary-to-sars-cov-2-16255https://curecurrent.com/trials/therapeutic-conflicts-and-multimorbidity-16256https://curecurrent.com/trials/diabetes-intervention-accentuating-diet-and-enhancing-metabolism-16257https://curecurrent.com/trials/the-diabetes-virus-detection-and-intervention-trial-16258https://curecurrent.com/trials/to-assess-the-efficacy-of-investigational-product-on-the-neuropathic-pain-in-individuals-suffering-from-type-ii-diabetes-16259https://curecurrent.com/trials/effects-of-glucose-lowering-agents-in-south-asian-women-with-impaired-glucose-tolerance-or-impaired-fasting-glucose-16260https://curecurrent.com/trials/icg-pdt-periimplantitis-diabetes-mellitus-16261https://curecurrent.com/trials/metabolic-benefits-of-drinking-blueberry-tea-in-type-2-diabetes-16262https://curecurrent.com/trials/the-influence-of-advanced-age-obesity-and-diabetes-type-on-course-and-outcome-of-pregnancy-with-diabetes-mellitus-16263https://curecurrent.com/trials/effect-of-suplementation-of-vitamin-d-in-gestational-diabetes-mellitus-16264https://curecurrent.com/trials/proadrenomedullin-and-copeptin-in-patients-with-septic-shock-16265https://curecurrent.com/trials/subclinical-diabetes-confirmed-by-75gm-ogtt-influence-on-the-prognosis-of-decompensated-cirrhosis-16266https://curecurrent.com/trials/empagliflozin-and-atrial-fibrillation-treatment-16267https://curecurrent.com/trials/transcutaneous-electrical-nerve-stimulator-to-improve-blood-glucose-control-in-patients-with-type-2-diabetes-mellitus-16268https://curecurrent.com/trials/trimaster-study-of-a-dpp4-inhibitor-sglt2-inhibitor-and-thiazolidinedione-as-third-line-therapy-in-patients-with-type-2-16269https://curecurrent.com/trials/intraoperative-insulin-administration-at-cardiac-surgery-for-diabetic-patients-16270https://curecurrent.com/trials/dual-wave-boluses-in-children-with-type-1-diabetes-insulin-boluses-in-children-with-type-1-diabetes-16271https://curecurrent.com/trials/pramlintide-and-fiasp-closed-loop-with-a-simple-meal-announcement-16272https://curecurrent.com/trials/factors-that-effect-the-gait-speed-in-diabetic-individuals-without-neuropathy-16273https://curecurrent.com/trials/glycosylated-hemoglobin-and-risk-of-perioperative-major-cardiovascular-events-in-diabetic-patients-undergoing-coronary-b-16274https://curecurrent.com/trials/additional-autoimmune-diseases-with-type-1-diabetes-in-pediatrics-at-diabetes-diagnosis-and-during-follow-up-16275https://curecurrent.com/trials/liraglutide-in-newly-onset-type-1-diabetes-16276https://curecurrent.com/trials/metabolic-efficiency-of-combined-pancreatic-islet-and-lung-transplant-for-the-treatment-of-end-stage-cystic-fibrosis-16277https://curecurrent.com/trials/comparison-of-lobeglitazone-with-pioglitazone-as-initial-triple-therapy-for-diabetes-management-16278https://curecurrent.com/trials/a-study-of-ly2963016-compared-to-lantus-in-adult-chinese-participants-with-type-1-diabetes-mellitus-16279https://curecurrent.com/trials/edcr-study-etanercept-diamyd-combination-regimen-open-trial-to-evaluate-safety-in-children-with-type-1-diabetes-16280https://curecurrent.com/trials/a-study-based-on-data-from-german-registries-that-looks-at-characteristics-of-people-who-take-the-medicine-empagliflozin-16281https://curecurrent.com/trials/demand-multifactorial-study-to-reduce-dementia-in-people-with-type-2-diabetes-16282https://curecurrent.com/trials/phase-3-study-to-evaluate-the-efficacy-and-safety-of-ormd-0801-in-subjects-with-type-2-diabetes-mellitus-16283https://curecurrent.com/trials/re-elect-dabigatran-vs-warfarin-in-af-patients-with-t2dm-and-ckd-16284https://curecurrent.com/trials/shoulder-musculoskeletal-disorders-in-type-2-diabetes-mellitus-contributing-factors-and-rehabilitation-protocol-16285https://curecurrent.com/trials/evaluation-of-the-1999-and-2018-periodontal-disease-classifications-a-retrospective-study-16286https://curecurrent.com/trials/phase-2a-study-examining-the-safety-and-efficacy-of-bol-dp-o-04-for-treating-diabetic-neuropathy-16287https://curecurrent.com/trials/foot-abnormalities-in-diabetic-ckd-patients-16288https://curecurrent.com/trials/dietary-fat-and-endothelial-function-in-type-1-diabetes-16289https://curecurrent.com/trials/bol-dp-o-05-as-an-add-on-treatment-of-subjects-with-newly-diagnosed-type-1-diabetes-mellitus-16290https://curecurrent.com/trials/parents-occupation-after-diabetes-onset-16291https://curecurrent.com/trials/aerobic-and-strength-training-exercises-for-restless-leg-syndrome-in-patients-with-diabetes-16292https://curecurrent.com/trials/mage-of-anagliptin-compared-with-sitagliptin-with-type-2-diabetes-mellitus-16293https://curecurrent.com/trials/retinal-neurodegeneration-in-type-2-diabetes-mellitus-detected-by-optical-coherence-tomography-16294https://curecurrent.com/trials/clear-sight-a-trial-of-non-mydriatic-ultra-widefield-retinal-imaging-to-screen-for-diabetic-eye-disease-16295https://curecurrent.com/trials/effect-of-dcc-on-neonatal-jaundice-and-blood-gas-analysis-in-infants-born-to-gdm-mothers-16296https://curecurrent.com/trials/ai-assisted-insulin-titration-system-on-inpatients-glucose-control-16297https://curecurrent.com/trials/dietary-reduction-of-ages-to-prevent-cognitive-decline-in-elderly-diabetics-16298https://curecurrent.com/trials/lifestyle-intervention-in-gestational-diabetes-living-16299https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-a-comprehensive-visceral-adiposity-focused-anti-obesity-program-16300https://curecurrent.com/trials/pharmacodynamic-study-of-biib095-and-biib074-in-healthy-participants-and-participants-with-painful-diabetic-polyneuropat-16301https://curecurrent.com/trials/effect-of-exercise-on-cardiometabolic-risk-factors-in-type-ii-diabetic-patients-16302https://curecurrent.com/trials/multifactorial-treatment-of-cardiovascular-risk-in-diabetic-patients-identification-of-treatment-non-responders-16303https://curecurrent.com/trials/uptake-of-telemedicine-system-trial-in-rual-canton-16304https://curecurrent.com/trials/information-networks-and-rewards-to-optimise-adherence-to-diabetic-services-16305https://curecurrent.com/trials/strength-and-balance-training-on-diabetic-peripheral-neuropathy-16306https://curecurrent.com/trials/lifestyle-intervention-in-type-2-diabetes-16307https://curecurrent.com/trials/myocardial-pathological-changes-in-patients-of-type-2-diabetes-with-or-without-pcos-using-cardiac-magnetic-resonance-16308https://curecurrent.com/trials/hcv-viral-hepatitis-blood-sugar-level-and-systolic-blood-pressure-in-egypt-16309https://curecurrent.com/trials/the-study-of-the-internet-monitoring-and-analysis-of-exercise-to-reduce-the-complications-of-diabetic-kidney-disease-16310https://curecurrent.com/trials/effect-of-pioglitazone-on-t2dm-patients-with-covid-19-16311https://curecurrent.com/trials/ga-6-the-blood-glucose-lowering-effect-of-glucose-dependent-insulinotropic-polypeptide-16312https://curecurrent.com/trials/hyperuricemia-and-diabetic-nephropathy-16313https://curecurrent.com/trials/motivational-interviewing-in-the-control-of-arterial-hypertension-and-type-2-diabetes-mellitus-16314https://curecurrent.com/trials/comparison-of-real-time-continuous-glucose-monitoring-with-self-monitoring-of-blood-glucose-in-young-adults-with-type-1-16315https://curecurrent.com/trials/motivational-interviewing-to-improve-self-management-in-youth-with-type-1-diabetes-16316https://curecurrent.com/trials/the-evaluation-of-consistency-by-finger-stick-blood-glucose-or-venous-blood-glucose-of-flash-glucose-monitoring-in-diffe-16317https://curecurrent.com/trials/promoting-weight-loss-and-stress-reduction-in-overweight-and-obese-patients-with-type-2-diabetes-16318https://curecurrent.com/trials/gliflozin-in-elderly-diabetic-patients-a-pragmatic-intraclass-evaluation-trial-16319https://curecurrent.com/trials/smarthealth-diabetes-in-china-using-lay-family-health-promoters-16320https://curecurrent.com/trials/reparixin-in-pancreatic-islet-transplantation-16321https://curecurrent.com/trials/diabetic-care-self-management-mobile-health-application-among-diabetes-mellitus-clients-in-malaysia-16322https://curecurrent.com/trials/the-efficiency-of-telemedicine-to-optimize-metabolic-control-in-patients-with-diabetes-in-turkey-16323https://curecurrent.com/trials/bariatric-surgery-and-male-reproductive-function-16324https://curecurrent.com/trials/a-study-of-tg103-in-subjects-with-type-2-diabetes-16325https://curecurrent.com/trials/insight-into-new-brown-adipose-tissue-activators-16326https://curecurrent.com/trials/a-single-supplement-of-a-standardised-bilberry-extract-modifies-glycaemic-response-16327https://curecurrent.com/trials/atrial-fibrillation-detected-by-continuous-ecg-monitoring-16328https://curecurrent.com/trials/healthy-eating-active-lifestyles-for-diabetes-feasibility-trial-16329https://curecurrent.com/trials/effect-of-liraglutide-on-the-metabolic-profile-in-patients-with-type-2-diabetes-and-cardiovascular-disease-16330https://curecurrent.com/trials/genetic-association-of-glucocorticoid-receptor-gene-polymorphisms-with-binge-eating-16331https://curecurrent.com/trials/restriction-of-dietary-ages-to-prevent-diabetes-in-overweight-individuals-16332https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-subcutaneously-administered-nnc01-16333https://curecurrent.com/trials/a-research-study-of-how-different-amounts-of-a-new-medicine-nnc0148-0287-c-insulin-287-works-on-the-blood-sugar-of-peopl-16334https://curecurrent.com/trials/the-incidence-of-diabetes-unawareness-in-patients-hospitalized-outside-internal-medicine-services-and-related-factors-16335https://curecurrent.com/trials/effects-of-agonists-of-glucagon-like-peptide-1-receptors-glp-1r-on-arterial-stiffness-endothelial-glycocalyx-and-coronar-16336https://curecurrent.com/trials/study-of-sulphonylurea-synergy-with-dpp4-inhibitors-16337https://curecurrent.com/trials/the-effect-of-a-perinatal-health-promotion-program-on-the-different-levels-of-gestational-hyperglycemic-women-16338https://curecurrent.com/trials/influence-of-diet-on-pregnancy-with-polyhydramnios-16339https://curecurrent.com/trials/the-relation-between-abdominal-obesity-type-2-diabetes-mellitus-and-knee-osteoarthritis-16340https://curecurrent.com/trials/the-impact-of-roto-track-in-helping-patients-with-diabetes-rotate-their-insulin-injections-better-16341https://curecurrent.com/trials/collaborative-care-model-on-type-2-diabetic-patients-16342https://curecurrent.com/trials/celiac-disease-and-diabetes-longitudinal-follow-up-and-evaluation-study-16343https://curecurrent.com/trials/a-study-of-empagliflozin-in-patients-with-refractory-diabetes-mellitus-with-insulin-resistance-16344https://curecurrent.com/trials/a-study-with-nly01-in-subjects-with-type-2-diabetes-16345https://curecurrent.com/trials/safety-and-efficacy-of-oral-semaglutide-versus-dulaglutide-both-in-combination-with-one-oad-oral-antidiabetic-drug-in-ja-16346https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-sitagliptin-once-daily-as-add-on-to-metformin-in-subjects-with-typ-16347https://curecurrent.com/trials/topical-menthol-mannitol-for-painful-diabetic-peripheral-neuropathy-16348https://curecurrent.com/trials/photobiomodulation-with-polarized-light-as-adjunctive-treatment-in-diabetic-foot-ulcer-16349https://curecurrent.com/trials/impact-of-community-pharmacist-involved-collaborative-care-model-for-the-management-of-type-2-diabetes-mellitus-16350https://curecurrent.com/trials/home-hit-and-type-1-diabetes-16351https://curecurrent.com/trials/platelet-function-in-diabetic-patients-with-and-without-renal-impairment-and-the-effects-of-lipid-lowering-treatment-16352https://curecurrent.com/trials/community-health-assessment-program-in-the-philippines-chap-p-16353https://curecurrent.com/trials/does-the-use-of-fiasp-vs-asp-lead-to-the-prolonged-tir-in-children-with-type-1-diabetes-16354https://curecurrent.com/trials/study-to-assess-the-efficacy-of-liraglutide-in-patients-with-type-2-diabetes-mellitus-16355https://curecurrent.com/trials/the-effect-of-soliqua-on-glucose-variability-in-type-2-patients-among-south-asians-16356https://curecurrent.com/trials/prevalence-and-risk-evaluation-of-diabetic-complications-of-the-foot-in-a-large-canadian-population-16357https://curecurrent.com/trials/transport-of-artificial-sweeteners-during-pregnancy-16358https://curecurrent.com/trials/covid-19-pandemic-patients-experience-in-t1d-16359https://curecurrent.com/trials/polyphenol-enriched-extra-virgin-olive-oil-and-postprandial-glycemia-in-type-1-diabetes-dop-16360https://curecurrent.com/trials/carbohydrates-under-target-for-type-1-diabetes-management-16361https://curecurrent.com/trials/the-influence-of-overfeeding-different-macronutrients-on-whole-body-insulin-sensitivity-16362https://curecurrent.com/trials/can-you-reduce-diabetes-symptomatology-by-becoming-your-best-possible-self-the-role-of-stress-and-resilience-16363https://curecurrent.com/trials/hit-on-hypoglycemic-risk-in-type-1-diabetes-t1d-16364https://curecurrent.com/trials/health-related-quality-of-life-and-psychosocial-aspects-of-diabetes-technology-insulin-pumps-16365https://curecurrent.com/trials/covid-19-and-diabetes-outcomes-16366https://curecurrent.com/trials/effect-of-soft-fruit-on-postprandial-blood-glucose-16367https://curecurrent.com/trials/a-study-of-the-safety-and-pharmacokinetics-of-an-anti-inflammatory-therapeutic-antibody-mabp1-in-patients-with-type-2-di-16368https://curecurrent.com/trials/covid-19-infection-in-diabetic-patients-16369https://curecurrent.com/trials/community-and-mhealth-based-integrated-management-of-diabetes-in-primary-healthcare-in-rwanda-16370https://curecurrent.com/trials/sitagliptin-and-the-risk-for-hypoglycaemia-in-type-2-diabetes-patients-16371https://curecurrent.com/trials/efficacy-of-pythagorean-self-awareness-for-aging-biomarkers-improvement-in-t2d-patients-and-healthy-individuals-16372https://curecurrent.com/trials/looking-for-personalized-nutrition-for-obesity-type-2-diabetes-mellitus-prevention-16373https://curecurrent.com/trials/hybrid-closed-loop-system-for-patients-on-multiple-daily-insulin-injections-16374https://curecurrent.com/trials/a-rural-optifast-intervention-for-partial-remission-of-type-2-diabetes-in-adults-with-obesity-16375https://curecurrent.com/trials/type-2-diabetes-and-bone-microarchitecture-16376https://curecurrent.com/trials/canadian-health-advanced-by-nutrition-and-graded-exercise-16377https://curecurrent.com/trials/dietary-interventions-on-glycocalyx-dimensions-in-south-asian-patients-with-diabetic-nephropathy-16378https://curecurrent.com/trials/benefits-of-using-various-starting-doses-of-atorvastatin-on-achievement-of-cholesterol-targets-16379https://curecurrent.com/trials/a-quality-ensuring-project-with-focus-on-patients-with-cardiovascular-diseases-as-well-as-type-2-diabetes-16380https://curecurrent.com/trials/low-calorie-diet-and-diabetes-16381https://curecurrent.com/trials/atorvastatin-and-ldl-profile-in-non-insulin-dependent-diabetes-mellitus-16382https://curecurrent.com/trials/africa-and-middle-east-cardiovascular-epidemiological-study-16383https://curecurrent.com/trials/is-real-time-cgm-superior-to-flash-glucose-monitoring-in-real-life-study-corrida-life-16384https://curecurrent.com/trials/evaluating-atorvastatin-with-omega-3-fatty-acids-in-cardiovascular-risk-reduction-in-patients-with-type-2-diabetes-16385https://curecurrent.com/trials/establish-the-benefits-of-using-various-starting-doses-of-atorvastatin-on-achievement-of-cholesterol-targets-actfast-16386https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-atorvastatin-in-patients-with-diabetes-and-high-cholesterol-16387https://curecurrent.com/trials/effect-of-cpap-treatment-on-glycemic-control-in-gestational-diabetes-a-pilot-randomized-controlled-trial-16388https://curecurrent.com/trials/copeptin-and-psychological-stress-of-medic-during-covid-19-pandemic-16389https://curecurrent.com/trials/observational-study-to-evaluate-the-efficacy-and-safety-of-suganon-tab-or-sugamet-xr-tab-16390https://curecurrent.com/trials/intermediate-and-long-acting-insulin-young-children-type-1-diabetes-16391https://curecurrent.com/trials/glucose-levels-in-early-pregnancy-and-feto-maternal-outcome-16392https://curecurrent.com/trials/fast-acting-insulin-aspart-and-insulin-pump-settings-16393https://curecurrent.com/trials/possible-role-of-roflumilast-in-diabetic-nephropathy-16394https://curecurrent.com/trials/treatment-adherence-intervention-in-patients-with-type-2-diabetes-and-comorbid-depression-16395https://curecurrent.com/trials/effects-of-the-insulin-self-titration-education-for-type-2-diabetes-mellitus-patients-16396https://curecurrent.com/trials/evaluating-remote-ischemic-conditioning-ric-and-standard-of-care-vs-sham-therapy-and-standard-care-16397https://curecurrent.com/trials/a-trial-to-assess-the-pharmacokinetics-safety-and-tolerability-of-semaglutide-in-healthy-chinese-subjects-16398https://curecurrent.com/trials/the-importance-of-meal-composition-on-preventing-exercise-induced-hypoglycemia-in-people-with-type-1-diabetes-16399https://curecurrent.com/trials/the-diabetes-transition-study-for-young-people-aged-between-16-20-years-of-age-16400https://curecurrent.com/trials/thyroid-dysfunction-in-patients-with-type-2-diabetes-with-early-diabetic-nephropathy-16401https://curecurrent.com/trials/beta-cell-function-in-glucose-abnormalities-and-acute-myocardial-infarction-16402https://curecurrent.com/trials/integrating-sex-and-gender-into-cpd-for-depression-diabetes-16403https://curecurrent.com/trials/short-term-intermittent-fasting-and-insulin-resistance-16404https://curecurrent.com/trials/optimization-of-glycemic-control-in-the-hospital-and-critical-care-setting-16405https://curecurrent.com/trials/blood-sample-measurements-and-physical-activity-levels-in-type-ii-diabetes-and-or-covid-19-16406https://curecurrent.com/trials/exercise-and-glp-1-ra-on-insulin-secretion-16407https://curecurrent.com/trials/living-with-statins-interventional-exercise-study-16408https://curecurrent.com/trials/a-study-evaluating-the-effects-of-a-high-viscosity-non-starch-polysaccharide-polyglycoplex-pgx-on-glycemic-control-cardi-16409https://curecurrent.com/trials/autologous-fat-grafting-in-the-treatment-of-critical-limb-ischaemia-16410https://curecurrent.com/trials/freestyle-libre-plus-bluetooth-transmitter-adjunct-can-this-improve-glucose-accuracy-and-reduce-burden-of-hypoglycaemia-16411https://curecurrent.com/trials/dapa-egypt-study-16412https://curecurrent.com/trials/comprehensive-care-protocol-in-new-diagnosis-of-type-2-diabetes-mellitus-and-associated-comorbidities-in-primary-care-16413https://curecurrent.com/trials/high-intensity-interval-training-hit-in-patients-with-type-2-diabetes-16414https://curecurrent.com/trials/a-research-study-comparing-active-drug-in-the-blood-in-healthy-participants-following-dosing-of-the-current-and-a-new-fo-16415https://curecurrent.com/trials/comparison-of-two-different-insulin-dose-calculation-algorithms-in-type-1-diabetes-16416https://curecurrent.com/trials/effect-of-eating-within-a-limited-time-on-sugar-sensitivity-and-liver-sugar-stores-of-people-with-type-2-diabetes-16417https://curecurrent.com/trials/impact-of-oral-probiotic-blend-on-pregnancy-outcome-16418https://curecurrent.com/trials/personalised-responses-to-dietary-composition-trial-16419https://curecurrent.com/trials/low-dose-dasiglucagon-for-prevention-of-insulin-induced-hypoglycemia-in-people-with-type-1-diabetes-16420https://curecurrent.com/trials/glycemic-and-insulinemic-responses-of-low-carbohydrate-snack-foods-16421https://curecurrent.com/trials/bioequivalence-study-for-fixed-dose-combination-zemimet-sr-tab-50-1000-and-coadministration-of-gemigliptin-50-mg-and-met-16422https://curecurrent.com/trials/lifestyle-intervention-in-individuals-with-low-or-high-genetic-risk-for-type-2-diabetes-16423https://curecurrent.com/trials/pregabalin-peripheral-neuropathic-pain-study-16424https://curecurrent.com/trials/effects-of-a-therapy-with-intravit-tablets-in-patients-with-diabetic-retinopathy-16425https://curecurrent.com/trials/intravitreal-aflibercept-injection-in-vitrectomized-eyes-for-treatment-of-diabetic-macular-edema-16426https://curecurrent.com/trials/effects-of-moringa-oleifera-leaves-on-glycemia-lipemia-and-inflammatory-profile-in-prediabetic-patients-16427https://curecurrent.com/trials/reccord-recording-courses-of-vascular-diseases-registry-16428https://curecurrent.com/trials/premixed-vs-basal-bolus-insulin-therapy-in-older-patients-with-type-2-diabetes-16429https://curecurrent.com/trials/effects-of-sglt2-inhibition-on-the-mechanisms-of-cardiac-damage-in-the-diabetic-patient-with-hfpef-16430https://curecurrent.com/trials/ferric-carboxymaltose-in-type-2-diabetes-mellitus-t2dm-patients-with-iron-deficiency-16431https://curecurrent.com/trials/association-of-non-alcoholic-fatty-liver-disease-and-diabetes-mellitus-16432https://curecurrent.com/trials/mesenchymal-stem-cells-to-treat-type-2-diabetes-16433https://curecurrent.com/trials/acute-effects-of-sglt2-inhibition-on-renal-oxygenation-and-autonomic-function-in-type-1-diabetes-16434https://curecurrent.com/trials/reward-using-the-retina-as-a-window-to-detect-cardiac-microvascular-dysfunction-in-diabetes-mellitus-16435https://curecurrent.com/trials/glucagon-like-peptide-1-receptor-glp1r-expression-and-beta-cell-mass-in-patients-with-type-2-diabetes-16436https://curecurrent.com/trials/a-study-on-the-efficacy-and-safety-of-gabapentin-in-the-treatment-of-patients-with-painful-diabetic-neuropathy-16437https://curecurrent.com/trials/the-effects-of-short-message-notifications-on-middle-aged-diabetic-patients-16438https://curecurrent.com/trials/metabolic-characteristics-of-a-novel-common-bean-product-16439https://curecurrent.com/trials/combination-of-ketogenic-diet-and-exercise-on-prediabetes-in-female-with-normal-weight-16440https://curecurrent.com/trials/faster-aspart-on-insulin-pump-treated-t1dm-patients-16441https://curecurrent.com/trials/effects-of-pilates-exercises-versus-walking-on-mechanical-and-vascular-variables-of-individuals-with-type-2-diabetes-mel-16442https://curecurrent.com/trials/steno-tech-explore-a-study-of-insulin-pump-users-with-type-1-diabetes-16443https://curecurrent.com/trials/the-effect-of-different-training-programs-on-patients-with-chronic-diseases-16444https://curecurrent.com/trials/effects-of-gestational-diabetes-mellitus-on-children-16445https://curecurrent.com/trials/a-single-center-retrospective-study-to-evaluate-the-clinical-performance-of-artificial-intelligence-medical-assisted-dia-16446https://curecurrent.com/trials/study-to-evaluate-efficacy-safety-and-tolerability-of-lyrica-in-patients-with-painful-diabetic-peripheral-neuropathy-16447https://curecurrent.com/trials/pilot-for-the-analysis-of-usability-in-the-use-of-the-diacare-platform-for-people-with-type-2-dm-and-their-professionals-16448https://curecurrent.com/trials/cardiometabolic-effects-of-rapid-glucose-excursion-16449https://curecurrent.com/trials/gut-microbiota-and-bile-acids-in-type-2-diabetes-mellitus-16450https://curecurrent.com/trials/comparison-of-two-biphasic-insulin-regimens-16451https://curecurrent.com/trials/cut-down-on-carbohydrate-usage-in-the-diet-of-type-2-diabetes-the-hypo-energetic-study-16452https://curecurrent.com/trials/insulin-in-treatment-of-diabetes-mellitus-with-pregnancy-16453https://curecurrent.com/trials/covid-19-lockdown-related-telemedicine-for-type-2-diabetes-16454https://curecurrent.com/trials/the-repose-relative-effectiveness-of-pumps-over-mdi-and-structured-education-trial-16455https://curecurrent.com/trials/role-of-nlrp3-in-periodontitis-and-diabetes-16456https://curecurrent.com/trials/the-effect-of-telephone-consulting-on-hba1-and-self-management-16457https://curecurrent.com/trials/joint-position-sense-plantar-sensation-balance-and-dual-task-performance-in-individuals-with-type-2-diabetes-16458https://curecurrent.com/trials/contextualizing-the-evidence-for-action-on-diabetes-cohort-16459https://curecurrent.com/trials/program-active-phase-2-16460https://curecurrent.com/trials/randomized-double-blind-multicenter-placebo-controlled-study-of-pregabalin-for-pain-associated-with-diabetic-peripheral-16461https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-pregabalin-for-the-treatment-of-diabetic-peripheral-neuropathy-or-postherpetic-neu-16462https://curecurrent.com/trials/a-study-to-evaluate-pregabalin-in-patients-with-painful-diabetic-peripheral-neuropathy-dpn-16463https://curecurrent.com/trials/the-together-on-diabetes-intervention-a-realist-evaluation-16464https://curecurrent.com/trials/a-long-term-study-to-evaluate-safety-and-efficacy-of-pregabalin-for-pain-associated-with-diabetic-peripheral-neuropathy-16465https://curecurrent.com/trials/anxiety-depression-and-eating-attitudes-of-diabetes-mellitus-patients-during-covid-19-lockdown-in-greece-16466https://curecurrent.com/trials/pharmacist-led-intervention-in-treatment-non-adherence-in-southwestern-nigeria-16467https://curecurrent.com/trials/effect-of-smartphone-based-telemedicine-and-education-in-patients-with-type-1-diabetes-mellitus-16468https://curecurrent.com/trials/differential-effects-of-vasopressin-and-oxytocin-on-attention-control-16469https://curecurrent.com/trials/a-study-comparing-the-injection-site-pain-experience-after-the-injection-of-semaglutide-b-and-semaglutide-d-with-2-diffe-16470https://curecurrent.com/trials/supplementation-of-brown-seaweed-on-insulin-resistance-of-nafld-patients-with-pre-or-type-2-diabetes-16471https://curecurrent.com/trials/a-research-study-looking-at-how-semaglutide-works-in-people-with-type-2-diabetes-in-united-kingdom-as-part-of-local-clin-16472https://curecurrent.com/trials/appropriate-strategy-of-surgical-treatment-in-ischemic-diabetic-foot-16473https://curecurrent.com/trials/second-generation-drug-eluting-stents-in-diabetes-16474https://curecurrent.com/trials/lifestyle-changes-reducing-type-2-diabetes-risk-among-arab-canadian-muslim-women-16475https://curecurrent.com/trials/the-use-of-faster-acting-aspart-in-type-1-diabetes-patients-16476https://curecurrent.com/trials/post-marketing-evaluation-of-mudan-granule-intervention-on-type-2-diabetic-peripheral-neuropathy-16477https://curecurrent.com/trials/effects-of-5-weeks-treatment-with-dapagliflozin-in-type-2-diabetes-patients-on-how-the-hormone-insulin-acts-on-sugar-upt-16478https://curecurrent.com/trials/returning-genome-and-metabolome-data-to-finterveys-2017-participants-p5-fi-finterveys-study-16479https://curecurrent.com/trials/contextualizing-evidence-for-action-on-diabetes-population-survey-16480https://curecurrent.com/trials/dose-response-safety-and-efficacy-of-oral-semaglutide-versus-placebo-and-versus-liraglutide-all-as-monotherapy-in-japane-16481https://curecurrent.com/trials/correlation-between-macular-ischemia-and-peripheral-ischemia-in-patients-with-diabetes-16482https://curecurrent.com/trials/a-study-to-look-at-how-safe-nnc0268-0965-is-in-healthy-people-and-people-with-type-1-diabetes-16483https://curecurrent.com/trials/effect-of-liraglutide-on-diastolic-dysfunction-on-cardiac-mri-in-type-2-diabetes-patients-16484https://curecurrent.com/trials/gemigliptin-and-biomarkers-of-kidney-injury-and-vascular-calcification-16485https://curecurrent.com/trials/high-resolution-ultrasound-in-lower-extremity-nerves-and-common-fibular-neuropathies-16486https://curecurrent.com/trials/repeated-educational-intervention-for-the-prevention-of-diabetic-foot-ulcers-in-high-risk-patients-16487https://curecurrent.com/trials/feasibility-and-safety-of-flash-glucose-monitoring-fgm-in-an-adult-italian-population-16488https://curecurrent.com/trials/nutritional-intervention-and-glycemic-improvement-in-patients-with-pre-diabetic-cystic-fibrosis-16489https://curecurrent.com/trials/effect-of-adding-renin-angiotensin-system-inhibitors-to-standard-antidiabetic-therapy-on-glycemic-control-in-patients-wi-16490https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-bone-metabolism-and-the-blood-sugar-of-evogliptin-and-dapagliflozin-16491https://curecurrent.com/trials/integrated-multidisciplinary-person-centered-care-for-patients-with-complex-comorbidities-heart-kidney-and-diabetes-16492https://curecurrent.com/trials/efficacy-of-a-brief-lifestyle-intervention-in-type-2-diabetes-compared-with-a-longer-group-educational-program-16493https://curecurrent.com/trials/magnesium-supplementation-in-diabetic-nephropathy-16494https://curecurrent.com/trials/efficacy-of-the-combination-of-isosorbide-dinitrate-spray-and-chitosan-in-diabetic-foot-ulcers-16495https://curecurrent.com/trials/vitamin-b12-supplementation-in-diabetic-neuropathy-16496https://curecurrent.com/trials/clinical-trial-of-trelagliptin-succinate-tablets-in-the-treatment-of-type-2-diabetes-16497https://curecurrent.com/trials/clinical-trial-to-investigate-the-pharmacokinetics-and-safety-of-ckd-393-16498https://curecurrent.com/trials/adherence-to-guidelines-vaccination-in-type-1-diabetes-mellitus-patients-avadi-1-16499https://curecurrent.com/trials/prognostic-imaging-biomarkers-for-diabetic-kidney-disease-16500https://curecurrent.com/trials/non-communicable-diseases-and-antiretroviral-therapy-outcomes-in-the-rapit-study-population-16501https://curecurrent.com/trials/safety-and-efficacy-of-viusid-and-asbrip-in-hospitalized-patients-infected-by-sars-cov-2-with-covid-19-16502https://curecurrent.com/trials/gastrointestinal-motility-among-diabetes-patients-16503https://curecurrent.com/trials/ciprofibrate-and-pre-diabetes-16504https://curecurrent.com/trials/research-study-for-rare-pathogenic-mutations-causing-type-2-diabetes-and-complications-16505https://curecurrent.com/trials/pilot-study-on-deep-learning-in-the-eye-16506https://curecurrent.com/trials/peripheral-nerve-block-in-patients-with-painful-diabetic-polyneuropathy-16507https://curecurrent.com/trials/trial-on-an-educative-structured-intervention-by-peer-educators-to-improve-hba1c-of-patients-with-type-2-diabetes-in-the-16508https://curecurrent.com/trials/human-versus-analogue-insulin-in-patients-after-pancreatectomy-16509https://curecurrent.com/trials/trial-of-steroid-avoidance-and-low-dose-cni-by-atg-induction-in-renal-transplantation-16510https://curecurrent.com/trials/visual-enhancement-device-in-low-vision-patients-16511https://curecurrent.com/trials/effects-of-aerobic-training-on-pancreatic-fat-and-cognitive-function-in-t2dm-patients-16512https://curecurrent.com/trials/fournier-s-gangrene-in-patient-with-uncontrolled-type-2-diabetes-16513https://curecurrent.com/trials/type-2-diabetic-patients-maintained-on-statin-therapy-16514https://curecurrent.com/trials/effects-of-mulberry-leaves-on-glycemic-control-in-patients-with-obesity-and-patients-with-type-2-diabetes-16515https://curecurrent.com/trials/insulin-glargine-u300-vs-insulin-degludec-u100-in-impact-on-the-glycaemic-and-cardiovascular-factors-16516https://curecurrent.com/trials/sumatriptan-and-glucose-16517https://curecurrent.com/trials/the-benefits-of-vitamin-b-combination-as-add-on-therapy-in-the-management-of-painful-diabetic-neuropathy-patient-16518https://curecurrent.com/trials/the-benefits-of-astaxanthin-as-add-on-therapy-in-the-management-of-painful-diabetic-neuropathy-patient-16519https://curecurrent.com/trials/alpha-lipoic-acid-and-diabetes-mellitus-potential-effects-on-peripheral-neuropathy-16520https://curecurrent.com/trials/the-benefits-of-vitamin-d-5000-iu-as-add-on-therapy-in-the-management-of-painful-diabetic-neuropathy-patient-16521https://curecurrent.com/trials/fracture-risk-after-pancreas-transplantation-frapat-16522https://curecurrent.com/trials/efficacy-and-long-term-safety-of-vildagliptin-as-add-on-therapy-to-metformin-in-patients-with-type-2-diabetes-16523https://curecurrent.com/trials/evaluation-of-quality-of-life-in-patients-with-type-1-diabetes-mellitus-during-the-covid-19-pandemic-16524https://curecurrent.com/trials/diabetic-artery-obstruction-is-it-possible-to-reduce-ischemic-events-with-cilostazol-16525https://curecurrent.com/trials/dapagliflozin-on-blood-pressure-variability-and-ambulatory-arterial-stiffness-index-in-hypertension-16526https://curecurrent.com/trials/development-of-diabetes-mobile-application-16527https://curecurrent.com/trials/effects-of-an-activity-control-system-in-patients-with-diabetes-a-randomized-controlled-trial-16528https://curecurrent.com/trials/case-control-study-of-inflammatory-breast-cancer-in-north-africa-16529https://curecurrent.com/trials/diabetes-treatment-in-rural-guatemala-16530https://curecurrent.com/trials/effects-of-exercise-intervention-and-confounding-factors-on-type-ii-diabetic-muscles-16531https://curecurrent.com/trials/molecular-taxonomy-of-surgically-harvested-ocular-tissues-defined-by-single-cell-transcriptomics-16532https://curecurrent.com/trials/study-of-the-gut-hormone-analogue-g3215-in-adult-subjects-16533https://curecurrent.com/trials/insulin-infusion-diabetes-ulcer-16534https://curecurrent.com/trials/quality-gaps-in-screening-and-monitoring-for-postoperative-hyperglycemia-in-a-canadian-hospital-16535https://curecurrent.com/trials/the-role-of-pregnancy-induced-gallbladder-dysmotility-in-the-pathophysiology-of-gestational-diabetes-mellitus-16536https://curecurrent.com/trials/an-innovative-approach-towards-understanding-and-arresting-type-1-diabetes-innodia-16537https://curecurrent.com/trials/effect-of-hbm-based-education-on-glycemic-control-of-type-2-diabates-patients-16538https://curecurrent.com/trials/dpp4-inhibitor-on-glycemic-variability-16539https://curecurrent.com/trials/drug-interaction-of-vildagliptin-laf237-with-voglibose-in-japanese-patients-with-type-2-diabetes-16540https://curecurrent.com/trials/predelivery-placental-biomarkers-pregnancy-and-delivery-outcome-16541https://curecurrent.com/trials/a-clinical-study-to-assess-the-effect-of-vildagliptin-on-beta-cell-function-in-drug-naive-patients-with-type-2-diabetes-16542https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-metformin-in-elderly-drug-naive-patients-with-type-2-diabetes-16543https://curecurrent.com/trials/pharmacokinetics-of-vildagliptin-in-mild-moderate-and-severe-renal-impaired-patients-16544https://curecurrent.com/trials/clinical-study-of-umbilical-cord-mesenchymal-stem-cells-in-the-treatment-of-type-2-diabetic-nephropathy-16545https://curecurrent.com/trials/vildagliptin-compared-to-gliclazide-in-combination-with-metformin-in-patients-with-type-2-diabetes-16546https://curecurrent.com/trials/long-term-safety-study-of-vildagliptin-in-patients-with-type-2-diabetes-16547https://curecurrent.com/trials/safety-and-tolerability-of-vildagliptin-versus-placebo-in-patients-with-type-2-diabetes-and-moderate-or-severe-renal-ins-16548https://curecurrent.com/trials/effect-of-vildagliptin-on-left-ventricular-function-in-patients-with-type-2-diabetes-and-congestive-heart-failure-16549https://curecurrent.com/trials/management-of-hyperglycemic-patients-in-emergency-medicine-department-16550https://curecurrent.com/trials/safety-and-tolerability-of-vildagliptin-versus-placebo-in-patients-with-type-2-diabetes-and-moderate-or-severe-renal-ins-16551https://curecurrent.com/trials/professional-continuous-glucose-monitoring-as-an-adjuvant-educational-tool-for-improving-glycemic-control-in-patients-wi-16552https://curecurrent.com/trials/metabolic-effects-of-the-sglt-2-inhibitor-empagliflozin-in-patients-with-diabetic-nephropathy-median-16553https://curecurrent.com/trials/metabolic-physical-responses-to-exercise-in-patients-with-type-2-diabetes-mellitus-16554https://curecurrent.com/trials/genetic-variants-replication-study-associated-with-dependence-on-sulfonylurea-in-participants-with-type-2-diabetes-16555https://curecurrent.com/trials/prophylactic-effect-of-conbercept-intravitreal-injection-at-the-conclusion-of-cataract-surgery-for-diabetic-macular-edem-16556https://curecurrent.com/trials/afamin-in-gestational-diabetes-mellitus-16557https://curecurrent.com/trials/the-effect-of-diabetes-mellitus-on-mortality-of-patients-with-covid-19-16558https://curecurrent.com/trials/high-intensity-rosuvastatin-vs-moderate-intensity-rosuvastatin-ezetimibe-in-high-atherosclerotic-cardiovascular-disease-16559https://curecurrent.com/trials/rosuvastatin-ezetimibe-versus-rosuvastatin-in-ascvd-patients-with-type-2-dm-16560https://curecurrent.com/trials/dual-add-on-therapy-in-type-2-diabetes-poorly-controlled-with-metformin-monotherapy-16561https://curecurrent.com/trials/the-diabetes-patient-takes-responsibility-16562https://curecurrent.com/trials/efficacy-of-fgm-in-pregestational-diabetes-16563https://curecurrent.com/trials/effects-of-fenofibrate-therapy-in-diabetic-nephropathy-16564https://curecurrent.com/trials/late-metabolic-effects-of-metformin-therapy-in-gestational-diabetes-16565https://curecurrent.com/trials/safety-and-efficacy-of-empagliflozin-in-pakistani-muslim-population-with-type-ii-diabetes-mellitus-16566https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-preference-regarding-convenience-of-medication-and-efficacy-safety-of-sugamet-xr-tablet-16567https://curecurrent.com/trials/effect-of-high-intensity-interval-training-on-cardiac-function-and-regulation-of-glycemic-control-in-diabetic-cardiomyop-16568https://curecurrent.com/trials/impact-of-an-interprofessional-shared-decision-making-and-goal-setting-decision-aid-for-patients-with-diabetes-16569https://curecurrent.com/trials/a-real-world-research-comparison-of-precision-and-experience-therapy-for-hypertension-diabetes-or-hyperlipidemias-16570https://curecurrent.com/trials/lipohypertrophy-monitoring-study-16571https://curecurrent.com/trials/diabetic-retinopathy-and-oct-a-changes-post-cataract-surgery-16572https://curecurrent.com/trials/diabetes-autoimmunity-withdrawn-in-established-patients-day-16573https://curecurrent.com/trials/study-to-evaluate-safety-efficacy-of-pbi-4050-its-effect-on-relevant-biomarkers-in-t2dm-patients-with-metabolic-syndrome-16574https://curecurrent.com/trials/a-trial-investigating-the-effect-of-oral-semaglutide-compared-with-placebo-on-postprandial-glucose-and-triglyceride-meta-16575https://curecurrent.com/trials/vaccination-coverage-in-people-linving-with-diabetes-16576https://curecurrent.com/trials/nutrient-profiling-and-bio-efficacy-of-wheat-barley-composite-flour-in-type-2-diabetes-a-in-randomized-control-clinical-16577https://curecurrent.com/trials/efficacy-safety-and-response-predictors-of-adjuvant-astragalus-therapy-for-diabetic-kidney-disease-16578https://curecurrent.com/trials/a-drug-drug-interaction-study-between-daclatasvir-and-metformin-16579https://curecurrent.com/trials/intensive-versus-standard-one-year-monitoring-on-glycaemic-control-after-initiating-csii-in-children-with-dt1-deep-study-16580https://curecurrent.com/trials/induction-of-immune-mediated-abscopal-effect-through-stereotactic-radiation-therapy-in-metastatic-melanoma-patients-trea-16581https://curecurrent.com/trials/advancing-insulin-prescribing-in-general-practice-16582https://curecurrent.com/trials/study-of-a-novel-non-invasive-glucose-monitoring-device-16583https://curecurrent.com/trials/adapted-physical-activity-study-16584https://curecurrent.com/trials/a-study-of-ly3209590-in-japanese-participants-with-type-2-diabetes-mellitus-16585https://curecurrent.com/trials/graded-exposure-in-patients-with-painful-diabetic-neuropathy-16586https://curecurrent.com/trials/postoperative-hyperbaric-oxygen-treatments-to-reduce-complications-in-diabetic-patients-undergoing-vascular-surgery-16587https://curecurrent.com/trials/inflammatory-axis-and-sirtuins-in-overweight-pre-diabetics-patients-16588https://curecurrent.com/trials/obstructive-sleep-apnea-and-diabetic-macular-edema-inflammatory-mediators-16589https://curecurrent.com/trials/urinary-incontinence-and-endocrine-factors-a-part-of-lolland-falster-health-study-lofus-16590https://curecurrent.com/trials/impact-of-alpha-lipoic-acid-ingestion-on-glucose-tolerance-in-subjects-with-pre-diabetes-16591https://curecurrent.com/trials/determination-of-automated-multiple-insulin-dose-injections-settings-using-the-mdi-smbg-advisor-for-patients-with-type-1-16592https://curecurrent.com/trials/a-trial-to-assess-safety-and-efficacy-of-ado09-versus-insulin-aspart-in-subjects-with-type-1-diabetes-mellitus-16593https://curecurrent.com/trials/determinants-of-cardiovascular-disease-kidney-disease-and-diabetes-16594https://curecurrent.com/trials/a-trial-to-compare-biochaperone-insulin-lispro-formulations-with-us-approved-humalog-and-with-eu-approved-humalog-in-pat-16595https://curecurrent.com/trials/biobran-mgn-3-increases-innate-resistance-and-reduces-the-incidence-of-influenza-like-illnesses-16596https://curecurrent.com/trials/novel-model-for-south-asian-treatment-in-diabetes-namaste-diabetes-trial-in-primary-care-16597https://curecurrent.com/trials/effect-of-combining-yoga-to-tens-on-diabetic-glaucoma-16598https://curecurrent.com/trials/cognitive-behavioral-therapy-for-adherence-in-patients-with-type-2-diabetes-16599https://curecurrent.com/trials/oxidative-stress-in-response-to-electroacupuncture-against-physical-activity-in-diabetic-patients-16600https://curecurrent.com/trials/comparison-of-mg-vs-k-supplementation-on-insomnia-in-diabetics-16601https://curecurrent.com/trials/remission-evaluation-of-a-metabolic-intervention-in-type-2-diabetes-with-forxiga-16602https://curecurrent.com/trials/energi-f703-for-diabetic-foot-ulcers-phase-ii-study-16603https://curecurrent.com/trials/hb-a1c-pre-and-post-confinement-in-latin-american-children-with-type-1-diabetes-dulce-study-group-16604https://curecurrent.com/trials/ulcers-electrical-stimulation-in-diabetic-foot-ulceration-16605https://curecurrent.com/trials/impact-of-social-distancing-on-bariatric-versus-non-surgical-obese-patients-during-covid-19-pandemic-16606https://curecurrent.com/trials/a-study-of-people-with-type-2-diabetes-who-have-diseases-that-affect-the-heart-and-blood-vessels-the-study-will-also-loo-16607https://curecurrent.com/trials/prevention-of-diabetes-in-overweight-obese-preadolescent-children-16608https://curecurrent.com/trials/25-hydroxyvitamin-d-levels-in-pregnancy-and-effects-on-pregnancy-related-disorders-16609https://curecurrent.com/trials/retinal-neurodegenerative-and-vascular-changes-in-diabetic-patients-16610https://curecurrent.com/trials/the-severity-of-covid-19-in-diabetes-and-non-diabetes-patients-16611https://curecurrent.com/trials/health-education-for-diabetes-mellitus-16612https://curecurrent.com/trials/meta-analysis-of-oats-for-diabetes-prevention-and-management-16613https://curecurrent.com/trials/the-effect-of-comprehensive-non-pharmacological-treatment-on-metabolic-disorders-in-type-2-diabetic-patients-16614https://curecurrent.com/trials/a-study-of-ly3209590-in-japanese-participants-with-type-2-diabetes-16615https://curecurrent.com/trials/effectiveness-of-health-management-of-glycemic-control-and-physical-activity-in-type-2-diabetes-mellitus-using-smartphon-16616https://curecurrent.com/trials/prevention-trial-immune-tolerance-with-alum-gad-diamyd-and-vitamin-d3-to-children-with-multiple-islet-autoantibodies-16617https://curecurrent.com/trials/tofogliflozin-glp-1-analogue-combination-trial-16618https://curecurrent.com/trials/preadmission-metformin-exposure-and-incidence-of-acute-kidney-injury-16619https://curecurrent.com/trials/effects-of-adding-triamcinolone-acetonide-to-conbercept-treatment-for-refractory-diabetic-macular-edema-conte-16620https://curecurrent.com/trials/verisee-software-for-diabetic-retinopathy-screening-16621https://curecurrent.com/trials/posterior-narrow-diameter-implants-in-hyperglycemic-and-normo-glycemic-patients-16622https://curecurrent.com/trials/a-clinical-trial-to-investigate-the-pharmacokinetic-drug-interaction-and-safety-of-ckd-501-d759-and-d150-ckd-393-16623https://curecurrent.com/trials/the-effect-of-dietary-fiber-enriched-cereals-on-glycemic-control-and-secretion-of-gut-hormones-16624https://curecurrent.com/trials/maxillary-sinus-floor-augmentation-in-diabetic-patients-16625https://curecurrent.com/trials/autodx-dr-prospective-clinical-validation-study-protocol-16626https://curecurrent.com/trials/resolution-of-type-2-diabetes-mellitus-intensive-vs-conventional-glycaemic-control-after-obesity-surgery-16627https://curecurrent.com/trials/remission-evaluation-of-a-metabolic-intervention-for-type-2-diabetes-with-iglarlixi-16628https://curecurrent.com/trials/microcirculatory-vasomotor-changes-in-type-2-diabetes-with-peripheral-neuropathy-16629https://curecurrent.com/trials/retinal-imaging-using-notal-oct-16630https://curecurrent.com/trials/clinical-trial-evaluating-the-safety-and-efficacy-of-the-use-of-chitosan-gel-in-patients-with-chronic-wounds-16631https://curecurrent.com/trials/the-effect-of-web-based-education-in-patients-with-type-2-diabetes-16632https://curecurrent.com/trials/mtpr-with-shockwave-on-pain-function-of-shs-in-stroke-16633https://curecurrent.com/trials/feasibility-and-efficacy-of-brief-behavior-change-counseling-on-lifestyle-in-hypertensive-and-diabetics-participants-16634https://curecurrent.com/trials/dose-finding-study-of-il-2-at-ultra-low-dose-in-children-with-recently-diagnosed-type-1-diabetes-16635https://curecurrent.com/trials/physical-therapy-for-diabetes-mellitus-16636https://curecurrent.com/trials/oral-anticoagulants-in-diabetic-and-nondiabetic-patients-with-non-valvular-atrial-fibrillation-organon-16637https://curecurrent.com/trials/middle-cerebral-and-umbilical-arteries-doppler-indices-in-the-prediction-of-adverse-neonatal-outcome-among-diabetic-preg-16638https://curecurrent.com/trials/role-of-markers-in-the-progression-of-diabetes-in-obese-patients-16639https://curecurrent.com/trials/effect-of-self-foot-exercise-on-the-incidence-of-plantar-foot-diabetic-ulcer-recurrence-16640https://curecurrent.com/trials/manipulating-narrative-presentations-of-information-to-encourage-good-foot-care-practice-in-people-with-and-without-diab-16641https://curecurrent.com/trials/management-of-diabetic-patients-with-telemedicine-in-the-context-of-the-covid-19-epidemic-16642https://curecurrent.com/trials/intravitreal-dexamethasone-vs-bevacizumab-in-aboriginal-people-with-dmo-16643https://curecurrent.com/trials/effect-of-dapagliflozin-on-blood-pressure-variability-in-prediabetes-and-prehypertension-16644https://curecurrent.com/trials/bimodal-and-coaxial-high-resolution-ophtalmic-imaging-16645https://curecurrent.com/trials/reducing-plasma-glucose-effect-of-cinnamon-in-type-2-diabetic-patients-in-the-municipality-of-comasagua-16646https://curecurrent.com/trials/ivabradine-to-treat-microalbuminuria-in-patients-with-type-2-diabetes-and-coronary-heart-disease-16647https://curecurrent.com/trials/metabolic-effects-of-whey-compounds-in-patients-with-diabetes-mellitus-type-2-16648https://curecurrent.com/trials/mesenchymal-stem-cells-to-intervene-in-the-development-of-type-1-diabetes-a-blinded-randomized-study-16649https://curecurrent.com/trials/differential-air-pressure-technology-for-treatment-of-diabetic-elderly-patients-16650https://curecurrent.com/trials/longitudinal-phenotyping-of-bariatric-surgery-patients-16651https://curecurrent.com/trials/educational-intervention-using-sms-to-evaluate-clinical-effects-and-satisfaction-in-patients-with-diabetes-mellitus-16652https://curecurrent.com/trials/diabetesflex-patient-involvement-and-patient-reported-outcome-measures-in-type-1-diabetes-16653https://curecurrent.com/trials/ahcl-system-initiation-in-t1d-patients-na-ve-to-technology-16654https://curecurrent.com/trials/evaluation-of-liraglutide-3-0mg-in-patients-with-poor-weight-loss-and-a-suboptimal-glucagon-like-peptide-1-response-16655https://curecurrent.com/trials/treatment-of-plantar-keratosis-with-medicinal-plant-in-diabetic-patients-16656https://curecurrent.com/trials/the-role-of-secretin-on-the-energy-homeostasis-16657https://curecurrent.com/trials/effects-of-oral-inositol-supplementation-on-obstetrics-outcomes-in-pcos-women-16658https://curecurrent.com/trials/liraglutide-effect-on-beta-cell-function-in-c-peptide-positive-type-1-diabetes-16659https://curecurrent.com/trials/the-wild-man-programme-a-nature-based-rehabilitation-enhancing-quality-of-life-for-men-on-long-term-sick-leave-16660https://curecurrent.com/trials/the-interaction-between-metformin-and-microbiota-the-memo-study-16661https://curecurrent.com/trials/the-impact-of-liraglutide-on-glucose-tolerance-and-the-risk-of-type-2-diabetes-in-women-with-previous-pregnancy-induced-16662https://curecurrent.com/trials/insulin-sensitivity-during-hyperbaric-oxygen-compared-to-hyperbaric-air-16663https://curecurrent.com/trials/determining-of-normal-values-and-conformity-assessment-of-the-dosage-of-a-plasmatic-marker-of-the-cellular-captation-of-16664https://curecurrent.com/trials/impact-intervention-16665https://curecurrent.com/trials/monotherapy-with-rapamycin-in-long-standing-type-1-diabetes-16666https://curecurrent.com/trials/effects-of-gut-peptides-on-bone-remodeling-ks-4-diabetes-19-16667https://curecurrent.com/trials/smarthealth-pregnancy-feasibility-acceptability-of-a-complex-intervention-for-high-risk-pregnant-women-in-rural-india-16668https://curecurrent.com/trials/acute-phase-response-periodontal-treatment-in-diabetes-affected-patients-16669https://curecurrent.com/trials/bone-marrow-vs-liver-as-site-for-islet-transplantation-16670https://curecurrent.com/trials/evaluation-of-education-for-gestational-diabetes-16671https://curecurrent.com/trials/in-and-ex-vivo-mitochondrial-function-of-the-heart-16672https://curecurrent.com/trials/meta-analysis-of-fish-oil-supplementation-and-cardiovascular-outcomes-in-diabetes-16673https://curecurrent.com/trials/the-irisin-and-metabolic-exercise-training-study-16674https://curecurrent.com/trials/islet-autotransplantation-in-patients-at-very-high-risk-pancreatic-anastomosis-16675https://curecurrent.com/trials/form-of-dairy-products-on-satiety-food-intake-and-post-meal-glycaemia-in-young-and-older-adults-16676https://curecurrent.com/trials/relationship-between-hba1c-level-sleep-quality-and-sleep-duration-16677https://curecurrent.com/trials/fluorescence-image-guided-healing-trial-16678https://curecurrent.com/trials/a-blinded-self-control-trial-to-evaluate-an-artificial-intelligence-based-cad-system-for-diabetic-retinography-16679https://curecurrent.com/trials/the-association-between-sucr-and-the-survival-in-patients-with-dkd-16680https://curecurrent.com/trials/antidiuretic-function-before-and-during-treatment-with-sglt2-inhibitors-16681https://curecurrent.com/trials/promoting-self-management-behaviors-in-adolescents-with-type-1-diabetes-using-digital-storytelling-16682https://curecurrent.com/trials/hypoglycaemia-and-cardiac-arrhythmias-in-type-2-diabetes-16683https://curecurrent.com/trials/impact-of-therapeutic-footwear-and-plantar-orthoses-on-diabetic-neuropathic-foot-in-quality-of-life-and-functionality-16684https://curecurrent.com/trials/clinical-assessment-of-a-closed-loop-insulin-delivery-system-16685https://curecurrent.com/trials/diabetes-prevention-using-sms-technology-16686https://curecurrent.com/trials/a-clinical-trial-to-investigate-the-pharmacokinetic-drug-interaction-and-safety-of-ckd-501-d745-and-d150-16687https://curecurrent.com/trials/investigating-re-dosing-with-otelixizumab-in-adults-with-newly-diagnosed-type-1-diabetes-mellitus-16688https://curecurrent.com/trials/effect-of-dapagliflozin-on-insulin-secretion-and-insulin-sensitivity-in-patients-with-prediabetes-16689https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-and-the-ability-for-pediatric-participants-with-type-2-diabetes-to-swallow-mk-043-16690https://curecurrent.com/trials/digital-foot-check-by-using-the-d-foot-a-new-software-16691https://curecurrent.com/trials/optimizing-metabolic-control-in-type-1-diabetes-the-automatic-bolus-calculator-flash-study-16692https://curecurrent.com/trials/early-intermittent-intensive-insulin-therapy-as-an-effective-treatment-of-type-2-diabetes-reset-it-main-trial-16693https://curecurrent.com/trials/using-polar-unite-fitness-watch-to-improve-cognition-for-t2dm-patients-16694https://curecurrent.com/trials/development-and-validation-of-a-self-administered-questionnaire-to-identify-levers-of-adhesion-behavior-to-patient-s-med-16695https://curecurrent.com/trials/colostrum-and-inflammation-16696https://curecurrent.com/trials/therapeutic-intervention-of-eriocitrin-in-the-reduction-of-hyperglycemia-in-pre-diabetic-individuals-16697https://curecurrent.com/trials/vaccination-coverage-and-level-of-protection-in-patients-at-risk-16698https://curecurrent.com/trials/millet-based-muffins-glycaemic-response-insulinemic-response-and-gastric-emptying-16699https://curecurrent.com/trials/culturally-sensitive-tools-for-ethnic-minorities-in-diabetes-self-management-education-and-support-16700https://curecurrent.com/trials/efficacy-and-safety-of-lucentis-use-in-patients-with-diabetic-macular-edema-evaluating-a-spaced-out-follow-up-after-inte-16701https://curecurrent.com/trials/efficacy-of-flash-glucose-sensing-technology-on-the-occurrence-of-cardiac-arrhythmias-associated-with-hypoglycemia-16702https://curecurrent.com/trials/clinical-assessment-of-a-novel-advanced-bolus-calculator-for-type-1-diabetes-5-16703https://curecurrent.com/trials/durability-of-combination-of-insulin-and-glp-1-receptor-agonist-or-sglt-2-inhibitors-versus-basal-bolus-insulin-regimen-16704https://curecurrent.com/trials/glimepiride-alogliptin-and-alogliptin-pioglitazone-combination-16705https://curecurrent.com/trials/effect-of-wf10-tcdo-on-hba1c-values-in-diabetic-foot-ulcer-patients-16706https://curecurrent.com/trials/the-korean-titration-study-comparison-of-the-self-titration-methods-for-glargine-300-16707https://curecurrent.com/trials/influence-of-a-liquid-oat-bran-product-on-blood-glucose-in-patients-with-poorly-controlled-type-2-diabetes-16708https://curecurrent.com/trials/effect-of-momordica-charantia-administration-on-type-2-diabetes-mellitus-insulin-sensitivity-and-insulin-secretion-16709https://curecurrent.com/trials/co-administration-of-thiamine-pyrophosphate-and-metformin-in-type-2-diabetes-16710https://curecurrent.com/trials/glycated-albumin-combined-with-body-composition-for-gestational-diabetes-mellitus-prediction-16711https://curecurrent.com/trials/the-factors-affecting-the-achievement-of-glucose-monitor-in-the-patients-on-diabetes-16712https://curecurrent.com/trials/flash-glucose-monitoring-study-for-diabetes-16713https://curecurrent.com/trials/effects-of-physical-activities-on-the-expression-of-nrf2-and-nf-kb-hemodialysis-patients-16714https://curecurrent.com/trials/clinical-trial-assessing-the-gnbac1-in-patients-with-onset-of-type-1-diabetes-within-4-years-16715https://curecurrent.com/trials/medstar-diabetes-pathway-chart-reviews-16716https://curecurrent.com/trials/laparoscopic-gastric-bypass-as-metabolic-surgery-in-obesity-class-1-16717https://curecurrent.com/trials/connected-healthcare-for-individuals-living-at-home-with-chronic-conditions-16718https://curecurrent.com/trials/effects-of-ginger-on-nonalcoholic-fatty-liver-disease-in-t2dm-16719https://curecurrent.com/trials/power-strength-training-in-type-2-diabetic-mellitus-older-adults-16720https://curecurrent.com/trials/platelet-rich-plasma-and-autologous-fat-graft-for-diabetic-ulcer-16721https://curecurrent.com/trials/the-efficacy-safety-and-immunogenicity-study-comparing-an-insulin-glargine-biosimilar-sansulin-log-g-to-lantus-16722https://curecurrent.com/trials/the-association-of-visceral-adiposity-index-with-progression-of-chronic-kidney-disease-16723https://curecurrent.com/trials/impact-of-tele-interventions-during-the-covid-19-pandemic-in-patients-with-diabetes-mellitus-16724https://curecurrent.com/trials/surgery-treatment-of-type-2-diabetes-mellitus-patients-with-grade-1-obesity-and-overweight-16725https://curecurrent.com/trials/effect-of-anesthesia-technique-on-early-outcome-in-diabetic-patients-undergoing-lower-extremity-amputation-16726https://curecurrent.com/trials/ehealth-intervention-on-physical-activity-for-type-2-diabetics-frustrated-by-covid-19-16727https://curecurrent.com/trials/clinical-trials-to-compare-the-effects-of-pioglitazone-and-evogliptin-on-hepatic-fibrosis-in-patients-with-chronic-hepat-16728https://curecurrent.com/trials/impact-of-act-based-interventions-on-diabetes-related-outcomes-16729https://curecurrent.com/trials/to-evaluate-the-effect-of-nesinaact-on-non-alcoholic-steatohepatitis-through-mri-and-liver-fibroscan-in-patients-with-ty-16730https://curecurrent.com/trials/study-on-appropriate-technology-of-standardized-diagnosis-and-treatment-for-diabetic-patients-with-pulmonary-infections-16731https://curecurrent.com/trials/noninvasive-glucose-measurements-database-and-calibration-compilation-16732https://curecurrent.com/trials/performance-under-sglt-2-inhibitors-in-humans-16733https://curecurrent.com/trials/performance-and-safety-evaluation-of-a-novel-non-invasive-glucose-monitoring-device-and-evaluation-of-the-instructions-f-16734https://curecurrent.com/trials/calibration-of-a-non-invasive-glucose-measurement-device-and-assessment-of-its-performance-in-the-hypoglycemic-range-in-16735https://curecurrent.com/trials/performance-study-of-a-non-invasive-glucose-monitoring-device-prototype-16736https://curecurrent.com/trials/trial-of-intranasal-insulin-in-children-and-young-adults-at-risk-of-type-1-diabetes-16737https://curecurrent.com/trials/prucalopride-versus-placebo-in-gastroparesis-16738https://curecurrent.com/trials/probiotics-supplementation-effect-on-glucose-homeostasis-in-children-with-type-1-diabetes-16739https://curecurrent.com/trials/pragmatic-lifestyle-pregnancy-and-post-pregnancy-intervention-for-overweight-women-with-gestational-diabetes-mellitus-16740https://curecurrent.com/trials/mechanisms-of-insulin-resistance-and-exercise-in-south-asians-16741https://curecurrent.com/trials/effect-of-pneumoperitoneum-and-neuromuscular-block-on-renal-function-in-diabetes-patients-16742https://curecurrent.com/trials/effect-of-totum-63-active-ingredient-of-valedia-on-glucose-and-lipid-homeostasis-on-subjects-with-prediabetes-16743https://curecurrent.com/trials/effects-of-nopal-fractions-on-postprandial-glucose-regulation-and-appetite-variables-in-healthy-humans-16744https://curecurrent.com/trials/sleep-and-type-1-diabetes-16745https://curecurrent.com/trials/bariatric-surgery-and-fatty-liver-disease-16746https://curecurrent.com/trials/easy-diabetes-treatment-study-1-16747https://curecurrent.com/trials/relation-between-serum-uric-acid-and-metabolic-syndrome-in-type-2-dm-16748https://curecurrent.com/trials/diabetes-outcomes-in-covid-19-pandemic-16749https://curecurrent.com/trials/insulin-infusion-and-infectious-diabetic-foot-ulcers-iiifu-16750https://curecurrent.com/trials/be-healthy-in-pregnancy-b-hip-a-trial-to-study-nutrition-and-exercise-approaches-for-healthy-pregnancy-16751https://curecurrent.com/trials/optimized-cardioprotection-therapy-in-obese-subjects-with-cad-16752https://curecurrent.com/trials/glycaemic-markers-in-persons-with-type-2-diabetes-on-peritoneal-dialysis-16753https://curecurrent.com/trials/curcumin-supplement-in-nonalcoholic-fatty-liver-patients-16754https://curecurrent.com/trials/the-efficacy-and-safety-of-paz320-on-ppg-and-insulin-blood-levels-in-type-ii-diabetic-patients-16755https://curecurrent.com/trials/app-technology-to-increase-physical-activity-among-patients-with-type-2-diabetes-16756https://curecurrent.com/trials/a-performance-evaluation-of-the-harmony-1-sensors-in-adults-and-pediatrics-16757https://curecurrent.com/trials/validation-of-medication-non-adherence-model-uk-16758https://curecurrent.com/trials/intensive-insulin-treatment-and-ischemic-foot-ulcer-16759https://curecurrent.com/trials/a-clinical-trial-of-overweight-obesity-with-type-2-diabetes-16760https://curecurrent.com/trials/remote-ischemic-conditioning-and-diabetic-foot-ulcers-16761https://curecurrent.com/trials/effect-of-insulin-degludec-versus-insulin-glargine-on-glycemic-variability-in-patients-with-type-2-diabetes-mellitus-16762https://curecurrent.com/trials/improvement-of-care-for-outpatients-with-type-2-diabetes-through-self-care-multidisciplinary-workshop-for-diabetes-16763https://curecurrent.com/trials/genetics-of-type-2-diabetes-among-han-chinese-16764https://curecurrent.com/trials/reflexology-in-diabetic-neuropathic-pain-management-16765https://curecurrent.com/trials/the-effects-of-light-on-glucose-metabolism-16766https://curecurrent.com/trials/clinical-research-of-uc-mscs-in-the-treatment-of-diabetic-nephropathy-16767https://curecurrent.com/trials/verify-a-study-to-compare-combination-regimen-with-vildagliptin-metformin-versus-metformin-in-treatment-na-ve-patients-w-16768https://curecurrent.com/trials/an-exploratory-study-on-the-application-of-continuous-glucose-monitoring-system-in-the-measurement-of-individual-glycemi-16769https://curecurrent.com/trials/safety-and-efficacy-of-the-glucome-app-in-patients-with-uncontrolled-diabetes-treated-with-mdi-16770https://curecurrent.com/trials/validation-of-biomarkers-of-diabetic-nephropathy-in-type-i-diabetic-children-16771https://curecurrent.com/trials/de-por-vida-a-diabetes-risk-reduction-intervention-for-hispanic-women-16772https://curecurrent.com/trials/glucome-usability-study-16773https://curecurrent.com/trials/atheroma-progression-and-vulnerability-under-continuous-glucose-monitoring-16774https://curecurrent.com/trials/copeptin-in-outcome-prediction-of-an-acute-psychotic-episode-16775https://curecurrent.com/trials/using-the-lumen-device-for-prediabetes-prevention-16776https://curecurrent.com/trials/clinical-decision-support-algorithm-to-predict-diabetic-retinopathy-16777https://curecurrent.com/trials/pharmacists-improving-refugees-adherence-and-knowledge-of-their-chronic-medications-16778https://curecurrent.com/trials/brain-and-cognitive-function-of-patients-with-rpd-16779https://curecurrent.com/trials/studies-of-empagliflozin-and-its-cardiovascular-renal-and-metabolic-effects-16780https://curecurrent.com/trials/treatment-of-hypoglycemia-in-type-1-diabetes-16781https://curecurrent.com/trials/study-on-the-feasibility-of-community-doctors-guided-by-specialists-to-use-basic-insulin-16782https://curecurrent.com/trials/the-effectiveness-of-intervention-on-insulin-injection-16783https://curecurrent.com/trials/contrast-nephropathy-in-type-2-diabetes-16784https://curecurrent.com/trials/the-influence-of-metformin-on-chronic-heart-failure-clinical-course-in-patients-with-prediabetes-16785https://curecurrent.com/trials/atorvastatin-for-the-treatment-of-lithium-induced-nephrogenic-diabetes-insipidus-16786https://curecurrent.com/trials/effects-of-prebiotics-on-glp-1-in-type-2-diabetes-16787https://curecurrent.com/trials/colonic-motility-in-patients-with-diabetes-16788https://curecurrent.com/trials/food-literacy-and-type-1-diabetes-16789https://curecurrent.com/trials/anti-inflammatory-status-in-dm2-treated-patients-16790https://curecurrent.com/trials/economic-crisis-and-adherence-to-the-mediterranean-diet-cassiopea-16791https://curecurrent.com/trials/efficacy-of-amoxicillin-metronidazole-compared-to-clindamycin-in-patients-with-periodontitis-and-diabetes-16792https://curecurrent.com/trials/automated-structured-education-based-on-an-app-and-ai-in-chinese-patients-with-type-1-diabetes-16793https://curecurrent.com/trials/effect-of-walking-on-sand-with-dietary-intervention-in-overweight-type-2-diabetes-mellitus-patients-16794https://curecurrent.com/trials/crtd-responders-optimization-16795https://curecurrent.com/trials/effects-of-rf-on-clopidogrel-resistance-in-patients-at-high-cardiovascular-risk-16796https://curecurrent.com/trials/barriers-to-eye-screening-for-people-with-diabetes-in-india-16797https://curecurrent.com/trials/efficacy-of-metformin-versus-sitagliptin-on-benign-thyroid-nodules-in-type-2-diabetes-16798https://curecurrent.com/trials/pharmacist-led-therapeutic-nutritional-intervention-in-type-2-diabetes-16799https://curecurrent.com/trials/compliance-of-diabetic-patients-treated-with-metformin-16800https://curecurrent.com/trials/project-frazier-3-regulatory-clinical-evaluation-16801https://curecurrent.com/trials/allogeneic-abcb5-positive-stem-cells-for-treatment-of-dfu-malum-perforans-16802https://curecurrent.com/trials/actions-insights-evaluating-a-novel-diabetes-management-solution-16803https://curecurrent.com/trials/pomegranate-consumption-by-poly-medicated-metabolic-syndrome-patients-16804https://curecurrent.com/trials/glucose-monitoring-programme-singaporee-glimpse-16805https://curecurrent.com/trials/insulin-resistance-in-primary-hyperparathyroidism-16806https://curecurrent.com/trials/lucentis-ranibizumab-in-diabetic-macular-oedema-a-treatment-evaluation-16807https://curecurrent.com/trials/evaluation-of-safety-of-low-level-laser-device-treatment-in-chronic-wounds-16808https://curecurrent.com/trials/a-pivotal-study-to-evaluate-guardian-connect-cgm-system-performance-in-china-16809https://curecurrent.com/trials/ranibizumab-in-diabetic-vitrectomy-a-prospective-randomised-controlled-trial-of-ranibizumab-pre-treatment-in-diabetic-vi-16810https://curecurrent.com/trials/customer-outcomes-value-experiencing-a-new-monitoring-technology-16811https://curecurrent.com/trials/alpha-tocopherol-beta-carotene-cancer-prevention-atbc-study-16812https://curecurrent.com/trials/impact-of-the-type-of-reconstruction-methods-on-diabetes-following-laparoscopic-distal-gastrectomy-in-patients-with-gast-16813https://curecurrent.com/trials/obstructive-sleep-apnoea-in-patients-with-type-1-diabetes-16814https://curecurrent.com/trials/serum-biomarkers-associated-with-postpartum-t2dm-in-women-with-gdm-16815https://curecurrent.com/trials/the-effect-of-black-currant-on-postprandial-glucose-metabolism-16816https://curecurrent.com/trials/study-of-human-adipose-tissue-loshat-16817https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-tolerability-pk-pd-and-efficacy-of-kbp-089-in-patients-with-t2dm-16818https://curecurrent.com/trials/phase-4-study-of-the-efficacy-of-losartan-based-therapy-in-hypertensives-with-and-without-diabetes-16819https://curecurrent.com/trials/effect-of-supplementation-with-hmb-and-glutamine-in-wound-healing-on-bloody-areas-16820https://curecurrent.com/trials/the-effectiveness-of-flash-glucose-monitoring-system-on-glycemic-control-in-patients-with-new-onset-type-2-diabetes-16821https://curecurrent.com/trials/closing-the-loop-in-adults-with-type-1-diabetes-under-free-living-conditions-16822https://curecurrent.com/trials/risk-factors-for-the-development-of-diabetes-mellitus-after-distal-pancreatectomy-16823https://curecurrent.com/trials/hospitalized-children-and-adolescent-patients-with-type-1-diabetes-during-the-covid-19-pandemic-in-egypt-16824https://curecurrent.com/trials/functional-improvement-of-progenitor-cells-and-endothelial-function-by-vildagliptin-in-diabetes-mellitus-finnja-dm-16825https://curecurrent.com/trials/kidney-biopsy-indications-in-type-2-diabetes-patients-16826https://curecurrent.com/trials/single-center-clinical-study-of-early-diagnosis-of-diabetic-cardiomyopathy-with-flim-16827https://curecurrent.com/trials/effect-of-green-tea-extract-on-lipids-in-patients-with-type-2-diabetes-16828https://curecurrent.com/trials/effects-of-structured-exercise-regime-in-gestational-diabetes-mellitus-16829https://curecurrent.com/trials/cell-therapy-for-peripheral-arterial-disease-and-diabetes-16830https://curecurrent.com/trials/glycemic-control-among-children-and-adolescents-with-type-1-diabetes-during-covid-19-pandemic-in-egypt-16831https://curecurrent.com/trials/dpp-4-inhibitors-and-acute-myocardial-infarction-effects-on-platelet-function-16832https://curecurrent.com/trials/possible-ameliorating-effect-of-n-acetylcysteine-nac-on-type-ii-diabetes-induced-nephropathy-16833https://curecurrent.com/trials/beneficial-effects-of-quinoa-chenopodium-quinoa-willd-in-the-prevention-of-type-2-diabetes-mellitus-16834https://curecurrent.com/trials/effect-of-sodium-glucose-co-transporter-2-inhibitor-on-inflammatory-cytokine-in-type-2-diabetes-16835https://curecurrent.com/trials/dietary-pattern-and-metabolic-health-study-16836https://curecurrent.com/trials/effect-of-periodontal-therapy-in-the-systemic-status-of-individuals-with-chronic-periodontitis-and-diabetes-type-2-16837https://curecurrent.com/trials/glycemic-control-in-t2dm-through-non-surgical-periodontal-therapy-16838https://curecurrent.com/trials/management-of-type-2-diabetes-after-gastric-bypass-surgery-16839https://curecurrent.com/trials/tubular-markers-in-response-to-saxagliptin-therapy-16840https://curecurrent.com/trials/effect-of-transcranial-direct-current-stimulation-on-sensory-integration-16841https://curecurrent.com/trials/effects-of-non-nutritive-sweeteners-on-the-composition-of-the-gut-microbiome-16842https://curecurrent.com/trials/randomized-open-label-trial-of-inhibitory-effect-of-evogliptin-on-progression-of-cavd-16843https://curecurrent.com/trials/induce-intellin-diabetic-foot-feasibility-study-16844https://curecurrent.com/trials/application-of-ucpcr-as-a-testing-tool-for-identification-of-mody-patients-in-the-uae-16845https://curecurrent.com/trials/bone-marrow-derived-allogeneic-mesenchymal-stromal-cells-to-non-healing-diabetic-foot-wounds-16846https://curecurrent.com/trials/a-study-to-observe-clinical-effectiveness-of-canagliflozin-300-mg-containing-treatment-regimens-in-indian-type-2-diabete-16847https://curecurrent.com/trials/copeptin-serum-level-in-liver-transplant-recipients-16848https://curecurrent.com/trials/diabetes-to-go-an-inpatient-diabetes-survival-skills-education-program-16849https://curecurrent.com/trials/performance-characteristics-of-non-invasive-glucose-monitoring-device-prototypes-16850https://curecurrent.com/trials/determining-the-feasibility-of-implementing-a-combined-cognitive-and-exercise-training-program-for-older-adults-in-a-com-16851https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-acarbose-metformin-sitagliptin-combination-treatment-in-dm-patients-16852https://curecurrent.com/trials/new-onset-endocrine-dysfunction-after-acute-pancreatitis-16853https://curecurrent.com/trials/diabetes-as-an-accelerator-of-cognitive-impairment-and-alzheimer-s-disease-16854https://curecurrent.com/trials/type-2-diabetes-and-obesity-in-mexican-pimas-gene-environment-interaction-16855https://curecurrent.com/trials/community-based-management-of-diabetes-in-nepal-16856https://curecurrent.com/trials/the-effects-of-bay1193397-on-skin-capillary-blood-flow-and-transcutaneous-oxygen-pressure-16857https://curecurrent.com/trials/teach-back-educational-method-on-diabetes-knowledge-level-16858https://curecurrent.com/trials/impact-of-dapagliflozin-on-diastolic-dysfunction-in-type-2-diabetic-patients-16859https://curecurrent.com/trials/safety-and-efficacy-of-spil1033-in-subjects-with-type-2-diabetes-mellitus-16860https://curecurrent.com/trials/efficiency-of-a-nursing-intervention-in-sleep-hygiene-16861https://curecurrent.com/trials/a-comparison-of-clinical-parameters-in-with-and-without-abnormal-glucose-tolerance-16862https://curecurrent.com/trials/efficacy-of-pioglitazone-hydrochloride-and-metformin-hydrochloride-tablets-on-the-patients-with-newly-diagnosed-type-2-d-16863https://curecurrent.com/trials/adaptive-real-time-intelligent-system-to-enhance-self-care-of-chronic-disease-16864https://curecurrent.com/trials/short-term-impact-of-covid-19-lockdown-on-metabolic-control-of-type-2-diabetes-16865https://curecurrent.com/trials/bm-mnc-and-ucmsc-for-type-2-diabetes-mellitus-patients-16866https://curecurrent.com/trials/estimation-of-fetal-weight-by-mr-imaging-to-predict-neonatal-macrosomia-premacro-study-16867https://curecurrent.com/trials/development-of-a-methodology-to-design-a-high-order-sliding-mode-controller-for-drug-dosage-16868https://curecurrent.com/trials/loose-dose-combination-of-acarbose-and-metformin-for-t2dm-in-metformin-failure-patients-16869https://curecurrent.com/trials/a-longitudinal-study-of-choroidal-changes-after-cataract-surgery-in-eyes-with-diabetic-retinopathy-16870https://curecurrent.com/trials/a-study-of-ly900027-given-by-insulin-pump-to-participants-with-type-1-diabetes-mellitus-16871https://curecurrent.com/trials/patient-empowerment-through-predictive-personalised-decision-support-pepper-validation-study-16872https://curecurrent.com/trials/dapagliflozin-and-cholesterol-metabolism-in-type-2-diabetes-dm2-16873https://curecurrent.com/trials/mody-in-young-onset-diabetes-in-different-ethnicities-16874https://curecurrent.com/trials/effects-of-neuromuscular-electrical-stimulation-on-glucose-variability-in-patients-with-type-2-diabetes-16875https://curecurrent.com/trials/a-study-comparing-the-injection-site-pain-experience-after-the-injection-of-2-different-solutions-of-semaglutide-with-2-16876https://curecurrent.com/trials/post-marketing-surveillance-special-use-results-surveillance-on-long-term-use-with-tresiba-16877https://curecurrent.com/trials/tongji-maternal-and-child-health-cohort-16878https://curecurrent.com/trials/nephropathy-in-type-2-diabetes-and-cardio-renal-events-16879https://curecurrent.com/trials/acceptability-feasibility-and-effectiveness-of-a-worksite-intervention-to-lower-cardiometabolic-risk-in-south-africa-16880https://curecurrent.com/trials/pre-operative-carbohydrate-loading-patients-with-diabetes-undergoing-elective-colorectal-surgery-16881https://curecurrent.com/trials/safety-and-tolerability-study-of-cotadutide-in-japanese-obese-subjects-with-type-2-diabetes-melitus-16882https://curecurrent.com/trials/collection-of-blood-for-gene-expression-genomic-studies-in-individuals-with-diabetes-qatar-16883https://curecurrent.com/trials/sympathetic-activity-and-cardiometabolic-complications-16884https://curecurrent.com/trials/study-visceral-adipose-tissue-and-liver-stifness-in-a-retrospective-cohort-of-diabetes-mellitus-patients-16885https://curecurrent.com/trials/snp-study-of-dpp-4-and-glp-1r-in-chinese-people-including-diabetes-patients-16886https://curecurrent.com/trials/perifoveal-vascular-network-assessed-by-oct-angiography-in-type-i-diabetes-mellitus-16887https://curecurrent.com/trials/irape-irisin-and-il-34-in-patients-with-type-2-diabetes-16888https://curecurrent.com/trials/balance-and-motion-coordination-parameters-can-be-improved-in-patients-with-type-2-diabetes-16889https://curecurrent.com/trials/exercise-prediabetes-and-diabetes-after-renal-transplantation-16890https://curecurrent.com/trials/octa-metrics-repeatability-and-reproducibility-in-different-disorders-16891https://curecurrent.com/trials/performance-of-six-equations-for-estimating-resting-energy-expenditure-in-patients-with-type-2-diabetes-16892https://curecurrent.com/trials/the-prognostic-value-of-lactate-is-different-among-septic-patients-16893https://curecurrent.com/trials/artificial-intelligence-assisted-insulin-titration-system-16894https://curecurrent.com/trials/empagliflozin-and-acei-effects-on-hyperfiltration-between-study-16895https://curecurrent.com/trials/assessing-the-impact-of-the-covid-19-lockdown-on-metabolic-control-and-access-to-health-care-in-patients-with-diabetes-16896https://curecurrent.com/trials/information-motivation-behavioral-skills-model-s-effects-on-adolescents-with-type-1-diabetes-16897https://curecurrent.com/trials/metformin-versus-vildagliptin-in-reducing-risk-of-metabolic-syndrome-complications-progression-16898https://curecurrent.com/trials/a-tube-feeding-study-in-malnourished-population-with-diabetes-16899https://curecurrent.com/trials/bosentan-use-in-patients-with-diabetic-nephropathy-16900https://curecurrent.com/trials/efficacy-and-safety-of-gp40071-compared-to-novorapid-penfill-in-type-1-diabetes-mellitus-patients-16901https://curecurrent.com/trials/new-insulin-therapy-by-multiwave-bolus-16902https://curecurrent.com/trials/postprandial-walking-in-obese-pregnant-women-and-perinatal-outcomes-a-multicenter-randomized-clinical-trial-16903https://curecurrent.com/trials/stress-induced-hyperglycemia-in-trauma-16904https://curecurrent.com/trials/a-trial-of-the-jejunal-to-ileal-diversion-endoscopic-procedure-side-to-side-anastomosis-16905https://curecurrent.com/trials/poly-unsaturated-fatty-acids-in-the-preservation-of-dietary-effects-on-hepatosteatosis-and-energy-metabolism-in-type-2-d-16906https://curecurrent.com/trials/relationship-between-improvement-in-insulin-secretion-and-decrease-in-hba1c-in-glp-1-ra-therapy-in-t2dm-patients-16907https://curecurrent.com/trials/a-research-study-looking-at-how-novomix-works-in-people-with-type-2-diabetes-in-local-clinical-practice-in-algeria-16908https://curecurrent.com/trials/specific-clinical-experience-investigation-for-long-term-use-of-bydureon-16909https://curecurrent.com/trials/specific-clinical-experience-investigation-for-long-term-use-of-exenatide-byetta-subcutaneous-injection-16910https://curecurrent.com/trials/local-measures-to-prevent-diabetes-in-the-v-rnes-region-16911https://curecurrent.com/trials/the-impact-of-low-glycaemic-index-gi-biscuits-on-postprandial-glycaemia-using-the-continuous-glucose-monitoring-system-c-16912https://curecurrent.com/trials/metabolomics-and-wound-healing-in-diabetes-16913https://curecurrent.com/trials/c-peptide-correlation-with-microvascular-complications-in-t1dm-16914https://curecurrent.com/trials/effects-of-food-sequence-on-the-glycaemic-and-insulinaemic-responses-16915https://curecurrent.com/trials/the-glycemic-effect-of-added-sugar-on-bake-beans-16916https://curecurrent.com/trials/the-glycaemic-response-of-local-foods-using-the-continuous-glucose-monitoring-system-16917https://curecurrent.com/trials/safety-and-efficacy-study-of-trc150094-to-improve-the-cv-risk-in-subjects-with-diabetes-dyslipidemia-and-hypertension-16918https://curecurrent.com/trials/janagliflozin-treat-type-2-diabetes-mellitus-t2dm-inadequately-controlled-with-metformin-16919https://curecurrent.com/trials/serum-resistin-level-following-non-surgical-periodontal-therapy-in-diabetic-patients-with-chronic-periodontitis-16920https://curecurrent.com/trials/janagliflozin-treat-t2dm-monotherapy-16921https://curecurrent.com/trials/associations-between-diabetes-care-and-haptoglobin-genotype-on-outcomes-16922https://curecurrent.com/trials/pharmacokinetics-of-ultra-rapid-acting-insulin-lispro-ural-in-type-1-diabetes-mellitus-16923https://curecurrent.com/trials/a-single-center-study-to-evaluate-ticagrelor-mechanism-of-action-in-inhibiting-juvenile-platelet-adp-response-16924https://curecurrent.com/trials/offloading-interventions-for-diabetic-foot-problems-in-upper-egypt-16925https://curecurrent.com/trials/the-influence-of-hdl-function-on-cognitive-function-16926https://curecurrent.com/trials/xigduo-extended-release-xr-post-marketing-surveillance-16927https://curecurrent.com/trials/empagliflozin-and-sympathetic-nerve-traffic-16928https://curecurrent.com/trials/advanced-glycation-end-products-are-associated-with-diabetic-macular-edema-16929https://curecurrent.com/trials/treatment-of-morbidly-obese-adolescent-with-a-duodena-jejunal-liner-16930https://curecurrent.com/trials/sleep-extension-for-metabolic-health-16931https://curecurrent.com/trials/evaluation-of-the-function-stop-before-hypoglycemia-on-external-insulin-pump-16932https://curecurrent.com/trials/effects-of-insulin-glargine-and-lixisenatide-on-the-brain-16933https://curecurrent.com/trials/prevalence-and-risk-factors-of-epiretinal-membrane-in-diabetic-and-non-diabetic-patients-16934https://curecurrent.com/trials/optimizing-the-primary-prevention-of-type-2-diabetes-in-primary-health-care-16935https://curecurrent.com/trials/study-of-the-factors-favoring-the-transition-from-prediabetes-to-diabetes-on-reunion-island-16936https://curecurrent.com/trials/sitagliptin-treatment-in-diabetic-covid-19-positive-patients-16937https://curecurrent.com/trials/phase-ii-clinical-trial-to-evaluate-the-efficacy-and-safety-of-the-treatment-with-bpl-1-in-adult-patients-with-type-2-di-16938https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-liraglutide-in-the-treatment-of-type-2-diabetes-16939https://curecurrent.com/trials/renoprotective-effects-of-dapagliflozin-in-type-2-diabetes-16940https://curecurrent.com/trials/using-32-gauge-needles-with-lengths-of-5-mm-and-8-mm-on-pain-post-injection-leak-and-blood-glucose-16941https://curecurrent.com/trials/effects-of-an-indoor-cycling-program-on-cardio-metabolic-factors-in-women-with-obesity-and-normal-body-weight-16942https://curecurrent.com/trials/a-single-and-multiple-dose-study-of-mk-8521-in-healthy-and-obese-males-mk-8521-002-16943https://curecurrent.com/trials/pharmacokinetic-pk-bioequivalence-and-pharmacodynamics-pd-of-julphar-insulin-n-and-huminsulin-basal-16944https://curecurrent.com/trials/shear-wave-elastography-in-gestational-diabetes-mellitus-16945https://curecurrent.com/trials/pain-diabetic-peripheral-neuropathy-dpn-in-china-16946https://curecurrent.com/trials/fear-of-hypoglycemia-in-children-and-adolecents-with-type-1-diabetes-16947https://curecurrent.com/trials/randomized-comparative-study-of-sleeve-gastrectomy-versus-mgb-and-sasi-bypass-randomized-study-16948https://curecurrent.com/trials/phenotyping-individuals-with-neo-diagnosed-type-2-diabetes-at-risk-for-all-cause-mortality-16949https://curecurrent.com/trials/evaluation-of-the-benefit-at-6-months-of-a-3-weeks-spa-treatment-in-the-type-2-diabetic-patient-16950https://curecurrent.com/trials/methyldopa-for-reduction-of-dq8-antigen-presentation-in-at-risk-subjects-for-type-1-diabetes-16951https://curecurrent.com/trials/glycaemic-markers-in-persons-with-type-2-diabetes-on-haemodialysis-16952https://curecurrent.com/trials/plantar-pain-balance-and-foot-function-in-individuals-with-diabetes-mellitus-16953https://curecurrent.com/trials/albiglutide-versus-placebo-in-insulin-treated-subjects-with-new-onset-type-1-diabetes-mellitus-16954https://curecurrent.com/trials/cardiorespiratory-fitness-in-prediabetic-type-2-diabetic-and-healthy-individuals-16955https://curecurrent.com/trials/prospective-trial-of-dexamethasone-implant-for-treatment-na-ve-diabetic-macular-edema-16956https://curecurrent.com/trials/effects-of-exercise-on-patients-with-nonalcoholic-fatty-liver-disease-a-comparative-randomized-controlled-trial-16957https://curecurrent.com/trials/meta-analyses-of-the-effect-of-important-food-sources-of-sugars-on-cardiometabolic-risk-factors-16958https://curecurrent.com/trials/16-week-flexible-vs-8-week-semaglutide-titration-16959https://curecurrent.com/trials/the-genetic-effects-of-rs7903146-and-dietary-intake-on-type-2-diabetes-mellitus-risk-in-a-healthy-population-16960https://curecurrent.com/trials/the-effect-of-rapid-and-slow-glucose-fall-on-the-subsequent-glucose-production-in-people-with-type-1-diabetes-16961https://curecurrent.com/trials/genetic-causes-of-gestational-diabetes-in-the-emirati-population-16962https://curecurrent.com/trials/simplification-of-cf-related-diabetes-screening-at-home-16963https://curecurrent.com/trials/isomaltulose-vs-sucrose-postprandial-effect-on-incretin-profile-and-second-meal-effect-16964https://curecurrent.com/trials/diabetes-nutrition-algorithm-prediabetes-16965https://curecurrent.com/trials/diabetes-nutrition-algorithms-sugars-galactose-and-fiber-induced-metabolic-improvement-in-the-dietetic-treatment-of-type-16966https://curecurrent.com/trials/immediate-and-long-term-induction-of-incretin-release-by-artificial-sweeteners-2-16967https://curecurrent.com/trials/immediate-and-long-term-induction-of-incretin-release-by-artificial-sweeteners-1-16968https://curecurrent.com/trials/diabetes-nutrition-algorithms-in-patients-with-overt-diabetes-mellitus-16969https://curecurrent.com/trials/development-and-evaluation-of-mhealth-solutions-to-monitor-and-involve-cardiometabolic-patients-in-self-care-16970https://curecurrent.com/trials/relevance-of-ultrasound-screening-for-foetal-macrosomia-16971https://curecurrent.com/trials/reimbursement-study-of-continuous-glucose-monitoring-in-belgium-16972https://curecurrent.com/trials/tailored-bilio-pancreatic-limb-and-hba1c-10-years-post-mini-gastric-bypass-16973https://curecurrent.com/trials/efficacy-and-safety-of-umbilical-cord-mesenchymal-stem-cells-transplantation-in-patients-with-type-2-diabetes-mellitus-16974https://curecurrent.com/trials/mitochondrial-bioenergetics-and-role-in-cellular-damage-in-ischemic-myocardium-16975https://curecurrent.com/trials/determining-the-effect-of-vitamin-d-dyslipidemia-and-microvascular-in-patients-with-type-2-diabetes-16976https://curecurrent.com/trials/impact-of-pediatrician-intervention-on-the-smoking-habits-of-parents-of-sick-children-16977https://curecurrent.com/trials/evaluation-of-macular-structural-and-functional-function-following-extensive-retinal-laser-therapy-in-patients-with-prol-16978https://curecurrent.com/trials/a-study-of-ly900014-in-participants-with-type-1-diabetes-mellitus-16979https://curecurrent.com/trials/a-study-of-ly900014-in-participants-with-type-2-diabetes-on-insulin-injection-therapy-16980https://curecurrent.com/trials/bridging-income-generation-with-group-integrated-care-16981https://curecurrent.com/trials/a-study-of-ly900014-formulation-in-participants-with-type-1-diabetes-mellitus-using-insulin-pumps-16982https://curecurrent.com/trials/a-study-of-ly900014-in-participants-with-type-1-diabetes-on-insulin-injection-therapy-16983https://curecurrent.com/trials/effectiveness-of-nutrition-education-intervention-on-glycemic-control-hba1c-16984https://curecurrent.com/trials/indian-phenotype-registry-16985https://curecurrent.com/trials/efficacy-and-safety-of-the-insulin-glargine-lixisenatide-fixed-ratio-combination-lixilan-to-insulin-glargine-alone-on-to-16986https://curecurrent.com/trials/efficacy-and-safety-of-the-insulin-glargine-lixisenatide-fixed-ratio-combination-lixilan-to-lixisenatide-on-top-of-oral-16987https://curecurrent.com/trials/postprandial-glucodynamic-response-to-insulin-glargine-lixisenatide-fixed-ratio-combination-in-japanese-patients-with-ty-16988https://curecurrent.com/trials/efficacy-and-safety-of-lixilan-versus-insulin-glargine-alone-both-with-metformin-in-japanese-with-type-2-diabetes-mellit-16989https://curecurrent.com/trials/the-effect-of-mobile-medical-used-for-the-standardized-management-of-gestational-diabetes-16990https://curecurrent.com/trials/comparing-glycaemic-benefits-of-active-versus-passive-lifestyle-intervention-in-kidney-allograft-recipients-16991https://curecurrent.com/trials/the-effects-of-freshwater-clam-extract-on-blood-sugar-and-lipid-profile-in-prediabetes-patients-16992https://curecurrent.com/trials/transformation-of-indigenous-primary-healthcare-delivery-16993https://curecurrent.com/trials/effect-of-metformin-on-gut-microbiota-changes-and-glycemic-control-of-newly-diagnosed-type-2-diabetes-16994https://curecurrent.com/trials/the-effect-and-mechanism-of-mmp-9-in-inducing-atherosclerosis-16995https://curecurrent.com/trials/the-effect-of-exenatide-on-fasting-bile-acids-16996https://curecurrent.com/trials/individualized-carbohydrate-intake-strategy-to-improve-blood-glucose-control-16997https://curecurrent.com/trials/carbohydrate-based-strategies-to-prevent-exercise-induced-hypoglycemia-16998https://curecurrent.com/trials/effect-of-liraglutide-on-vascular-inflammation-in-type-2-diabetes-16999https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-for-12-days-in-adults-with-type-1-diabetes-17000